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Abstract
Wnt/β-catenin signalling plays a critical role in development and disease. The key
player of the pathway is β-catenin, which is able to shuttle between cytoplasm and
nucleus. In the nucleus, complex formation of β-catenin and TCF initiates target
gene expression. The activity of β-catenin is mainly regulated by the destruction
complex consisting of the scaffolding proteins APC and Axin, and the kinase GSK3.
In recent years, it has been shown that these antagonists are also capable of nucleo-
cytoplasmic shuttling, although their functional relevance in the nucleus remains
to date elusive. This study aims to investigate the impact of nucleo-cytoplasmic
shuttling of APC, Axin, and GSK3 on the [β-catenin/TCF] concentration, which
is considered as the output of the pathway. To this end, I establish and analyse
compartmental models encoded in ordinary differential equations, which are based
on experimental findings. These models allow for protein shuttling between the nu-
cleus and the cytoplasm and the resulting regulation of subcellular β-catenin levels
through retention and degradation. Using simulations of transient dynamics, as well
as steady state and sensitivity analyses, I gain the following key results: Nucleo-
cytoplasmic shuttling of β-catenin and its antagonists can lead to an increase of
the [β-catenin/TCF] concentration in contrast to a reference model without antag-
onist shuttling. I demonstrate that the total robustness of the [β-catenin/TCF]
output is closely linked to its absolute concentration. Therefore nucleo-cytoplasmic
shuttling also leads to an increased robustness of [β-catenin/TCF] signalling against
intracellular perturbations. In addition, I show that balanced shuttling of β-catenin
antagonists yields maximal relative response of [β-catenin/TCF] to a transient Wnt
signal. A sensitivity analysis moreover reveals that nuclear accumulation of the de-
struction complex renders the pathway robust against fluctuations in the extracellu-
lar Wnt signal and against changes in the compartmental distribution of β-catenin.
Thus my results strongly suggest that Wnt/β-catenin signalling can benefit from
nucleo-cytoplasmic shuttling of APC, Axin and GSK3, although they are in general
β-catenin antagonising proteins. These findings provide the basis for continuative
experimental investigations of antagonist shuttling in the Wnt pathway.
iii

Zusammenfassung
Der Wnt/β-catenin Signalweg spielt eine entscheidene Rolle in der Entwicklungs-
biologie und bei der Entstehung von Krankheiten. Das Protein β-catenin ist der
zentrale Protagonist dieses Signalweges. Im Nukleus bildet es gemeinsam mit TCF
einen Transkriptionsfaktorkomplex, der die Expression verschiedener Zielgene ein-
leitet. Die Aktivita¨t des β-catenin wird maßgeblich durch einen Abbaukomplex re-
guliert, der aus den Geru¨stproteinen APC und Axin, und der Kinase GSK3 besteht.
Diese Proteine sind Antagonisten des β-catenins und wie dieses in der Lage zwischen
Zytoplasma und Nukleus hin und her zu shutteln, wobei die funktionelle Relevanz
der Antagonisten im Zellkern bis heute nicht gekla¨rt ist. Ziel der vorliegenden Arbeit
ist die Untersuchung des nukleo-zytoplasmischen Shuttelns (NZS) der Antagonisten
und dessen Auswirkung auf die [β-catenin-TCF] Konzentration, die als Output des
Signalweges gilt. Zu diesem Zweck habe ich auf experimenteller Grundlage Kompar-
timentenmodelle entwickelt und analysiert, die auf Systemen von gekoppelten Differ-
entialgleichungen beruhen. Diese Modelle beschreiben das NZS des β-catenins und
seiner Antagonisten und die daraus resultierende Beeinflussung der subzellula¨ren β-
catenin Konzentration durch Retention und Abbau. Mittels Simulation der transien-
ten Dynamik, sowie durch Analyse des stationa¨ren Zustands und dessen Sensitivita¨t
gegenu¨ber Sto¨rungen, bin ich zu den folgenden Ergebnissen gekommen: Das NZS
der β-catenin Antagonisten kann im Vergleich zu einem Referenzmodel, in dem die
Antagonisten nicht shutteln, zu einer Maximierung der [β-catenin/TCF] Konzentra-
tion fu¨hren. Da ich zeigen konnte, dass die Gesamtrobustheit des [β-catenin/TCF]
Output stark an die absoluten Werte der [β-catenin/TCF] Konzentration gekop-
pelt ist, bewirkt das NZS der Antagonisten zusa¨tzlich eine erho¨hte Robustheit der
[β-catenin/TCF] Konzentration gegenu¨ber kleinsten intrazellula¨ren Sto¨rungen. Die
Modellanalyse belegt weiterhin, dass i) das NZS der Antagonisten zwischen den
Kompartimenten eine maximale Reaktion der [β-catenin/TCF] Konzentration auf
transiente Wnt Signale verursacht und ii) die Akkumulation des Abbaukomplexes
im Nukleus in einem robusten Output gegenu¨ber Fluktuationen des extrazellula¨ren
Wnt Signals und der zellula¨ren Verteilung des β-catenin resultiert. Diese Erkennt-
nisse verdeutlichen, dass der effektive Output des Wnt Signalweges von dem NZS
dieser Proteine profitieren kann, obgleich sie bisher nur fu¨r eine antagonistische Rolle
im Zytoplasma bekannt waren. Die Ergebnisse dieser Arbeit bieten die Basis fu¨r
weiterfu¨hrende experimentelle Untersuchungen der Rolle der Antagonisten im Wnt
Signalweg.
v
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1. Motivation and objectives
In order to maintain life, cells must continuously sense their external and internal
environment and induce changes on the basis of this information [Alberts et al.,
2002]. This processing of information is carried out by signalling pathways and net-
works [Wolkenhauer and Mesarovic´, 2005], which enable the cells to adapt to their
environment, continue or stop their development, and form more complex structures
through intercellular communication [Wolkenhauer et al., 2005]. During evolution,
living cells have developed means to control the temporal dynamics of signalling
pathways. However, recent findings emphasise the pivotal role that space plays in
intra- and intercellular dynamics [Kholodenko, 2006, Klipp et al., 2009]. Crucial
cell decisions, including whether to undergo proliferation, apoptosis (programmed
cell death) and differentiation, are governed by the temporal dynamics and spatial
distribution of key signalling proteins [Kholodenko et al., 2010]. Therefore, cells and
organisms show complex spatial structures that are vital for the processes of life.
Compartmentalisation is a major characteristic of eukaryotic cells, as demonstrated,
for example, for the Toll-like receptor function [Barton and Kagan, 2009]. The par-
titioning of a cell by membranes results in a separation of functional units and in the
formation of reaction spaces that might differ significantly in their molecular compo-
sition. This is due to a restricted permeability of the membranes and the controlled
shuttling of molecules, such as proteins, protein complexes and mRNA (messen-
ger ribonucleic acid), between the compartments, especially between the cytoplasm
and the nucleus [Klipp et al., 2009, Schmierer et al., 2008]. The importance of the
localisation of molecules in signalling in general and of compartmental shuttling
of proteins in particular, becomes apparent considering the Janus kinase - Signal
transducer and activator of transcription (JAK-STAT) pathway, which has been
studied in great detail [Beirer and Ho¨fer, 2006, Horvath, 2000]. In the JAK-STAT
pathway, the rapid signal transduction from the receptor to the nucleus is mediated
by STAT5. This central protein is phosphorylated on recruitment to the activated
receptor complex, where it is also dimerised. It then migrates to the nucleus, where
it stimulates the transcription of target genes. After dephosphorylation, the STATs
1
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are relocated back into the cytoplasm and recruited to the receptor complex, if it
is still active. Hence, STAT proteins continuously translocate between the nucleus
and the cytoplasm [Reich and Liu, 2006]. Using mathematical modelling, Swameye
et al. [2003] have identified nucleo-cytoplasmic shuttling as an essential feature of
the JAK-STAT core signalling module. They predicted that steps of nuclear import
and export are most sensitive to perturbations and experimentally verified these
predictions by inhibiting nuclear export.
Another example emphasising the central role of space is the nuclear factor-κB (NK-
κB) signalling module, whose output is regulated by spatio-temporal coordination
involving a negative feedback [Hoffmann et al., 2002, Kholodenko et al., 2010, Scott
and Pawson, 2009]. NF-κB is inactive in the cytoplasm when associated with the
inhibitor of NK-κB (IκB). Cell stimulation leads to phosphorylation and degrada-
tion of IκB, resulting in the release and subsequent translocation of free NF-κB into
the nucleus, where it activates target genes. Thereby, NF-κB initiates transcription
of its own inhibitor IκB, which can bind nuclear NF-κB and export it back to the
cytoplasm. This example shows that the spatial-temporal arrangement of signalling
proteins is subject to dynamic regulation and, vice versa, that spatial organisation
can specify kinetic activity profiles [Kholodenko et al., 2010]. In particular it demon-
strates that the nucleo-cytoplasmic shuttling of antagonists can play an essential role
in the regulation of the pathway activity.
In recent years, the nucleo-cytoplasmic shuttling of Wnt pathway components and
its role in regulating the signalling activity have come into focus of research [Cao
et al., 2009, Caspi et al., 2008, Li et al., 2010, 2012]. Wnt/β-catenin signalling is a
key regulatory system in development and disease [MacDonald et al., 2009]. The key
player of the pathway is β-catenin [Kikuchi, 2000]. Its activity is mainly regulated
by the destruction complex consisting of Adenomatous polyposis coli (APC), Axin
and Glycogen synthase kinase 3 (GSK3) [Stamos and Weis, 2012]. In the nucleus,
complex formation of β-catenin and T-cell factor (TCF) initiates target gene expres-
sion [Behrens et al., 1996, Mosimann et al., 2009]. However, not only β-catenin as a
transcriptional cofactor is able to translocate into and out of the nucleus. A surpris-
ingly high number of cytoplasmic Wnt regulators are shuttling proteins that have
been proven to also reside in the nucleus [Bijur and Jope, 2003, Neufeld et al., 2000,
Rosin-Arbesfeld et al., 2000, Wiechens et al., 2004], while their functional relevance
in the nucleus is still unclear. The goal of this thesis is to provide a comprehensive
analysis of the role of nucleo-cytoplasmic shuttling of β-catenin and its antagonists
2
APC, Axin, and GSK3 in Wnt/β-catenin signalling and the resulting regulation of
subcellular β-catenin levels. The purpose of my theoretical analysis is to inspire
biologists to design and perform new experiments. My study aims at answering the
following key questions: Does the nucleo-cytoplasmic shuttling of the β-catenin an-
tagonists APC, Axin and GSK3 affect the [β-catenin/TCF] concentration, which is
considered as the output of Wnt signalling? Can the [β-catenin/TCF] concentration
be maximised by antagonist shuttling, leading to an optimised signal transduction
through the cell? How is the output of the pathway influenced by cytoplasmic and
nuclear retention of β-catenin, and by phosphorylation and subsequent degradation
of β-catenin?
To answer these questions, I investigate the impact of nucleo-cytoplasmic antagonist
shuttling on [β-catenin/TCF] signalling using mathematical modelling. I define a
mathematical model as an abstract representation of a (in this case, biological) sys-
tem in which the interactions and dynamics of its components are described using the
language of mathematics. In this work, I design and analyse compartmental models
encoded in coupled ordinary differential equations (ODEs) that describe spatio-
temporal changes of pathway components as functions of molecular interactions and
transport processes. These ODE models are on a subcellular, compartmental scale
and allow for the retention of β-catenin by APC, and β-catenin phosphorylation
and successive degradation in the nucleus and cytoplasm, respectively.
Outline of this thesis
This thesis is structured into the following chapters: Chapter 2 provides the biolog-
ical background regarding the signal transduction of the Wnt/β-catenin pathway as
well as intracellular transport mechanisms of the involved proteins. In Chapter 3, I
give an introduction to mathematical modelling of spatio-temporal biochemical pro-
cesses in cells. In particular, I present the modelling framework and model analysis
techniques I decided to use in this thesis. Chapter 4 offers a survey of mathema-
tical models dealing with the Wnt pathway on a biochemical and subcellular level.
I conclude this literature review with summarising open questions regarding Wnt
pathway modelling. In Chapter 5, I investigate the impact of nucleo-cytoplasmic
shuttling of the antagonist APC on the [β-catenin/TCF] concentration. In this
model the β-catenin concentration is mainly regulated through compartmental re-
tention by APC (the “Retention Model”). This work has been published in [Schmitz
3
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et al., 2011] and is reproduced with permission from Elsevier. In Chapter 6, I in-
vestigate the influence of nucleo-cytoplasmic shuttling of the three antagonists APC,
Axin and GSK3 on the output of Wnt/β-catenin signalling. This compartmental
model is an extention of the Retention Model and allows for β-catenin degrada-
tion in both cellular compartments, cytoplasm and nucleus. It is referred to as the
“Degradation Model”. The work presented in this chapter has been published as
[Schmitz et al., 2013], and is reproduced with permission from Elsevier. Chapter 7
provides a comparison of the Retention Model and the Degradation Model and gives
a consolidation of all obtained results. Final remarks and a brief outlook to future
research conclude this thesis. An appendix provides supplemental material.
4
2. Signal transduction in the Wnt
pathway
The goal of this thesis is to provide a comprehensive analysis of the role of nucleo-
cytoplasmic shuttling of Wnt pathway components on the output of the pathway.
To this end, I build a model on the Wnt/β-catenin pathway and investigate the
dynamics of the model with the focus on nucleo-cytoplasmic shuttling of β-catenin
and its antagonists. In order to achieve this goal it is indispensable to understand
the background of signal transduction and intracellular transport in general, and
the Wnt/β-catenin pathway, in particular.
In this chapter I therefore present some of the key biological concepts necessary
to motivate, develop and comprehend the models presented in this thesis. I start
by giving an introduction to cellular signalling in Section 2.1 and then discuss the
Wnt signalling pathway in Section 2.2. Thereby, I provide an introduction to the
biological and biochemical function of the relevant key proteins. The description is
more detailed than necessary for the models that I present, in line with my inten-
tion to illustrate the complex nature of these proteins and their roles in signalling.
Section 2.3 summarises intracellular transport mechanisms in general. Finally, the
nucleo-cytoplasmic shuttling of the relevant Wnt pathway components is presented
in Section 2.4.
2.1. Cellular signalling
All cells, whether they live as individuals or in a multicellular organism, are bom-
barded by signals in many forms in a continual manner. It is the ability to sense and
respond to their environment that is crucial to their survival and therefore a funda-
mental characteristic of life [Hancock, 2010, Sauro and Kholodenko, 2004]. Cellular
signalling is equal to information processing. It controls the inner workings of all
organisms, allowing them to respond, adapt and survive [Hancock, 2010, Pollard and
Earnshaw, 2008]. The main principles, components and mechanisms of cellular sig-
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Figure 2.1.: Abstract representation of the main steps of signal transduction. An extra-
cellular signalling molecule binds to a receptor protein, thereby activating an intracellu-
lar signalling pathway that is mediated by a series of signalling proteins. Ultimately, the
signal reaches its final destination where the signalling protein interacts with a target
protein, resulting in a change of behaviour of the cell [Alberts et al., 2002, Figure 15-1,
page 832].
nalling are essentially the same across the diverse range of organisms, from bacteria,
fungi, plants and animals [Hancock, 2010]. The specificity of cellular responses to
external stimulation is encoded by the spatial and temporal dynamics of signalling
pathways and networks [Kholodenko, 2006]. In this way, complex biological pro-
cesses such as development, tissue function, immune response and wound healing
are precisely and dynamically regulated [Asthagiri and Lauffenburger, 2000].
Figure 2.1 illustrates the main steps of cellular signalling. The first step is the
recognition of the extracellular signalling molecule. Most stimuli from outside the
cell, including proteins and peptides, cannot penetrate the cell membrane. These
extracellular ligands bind transmembrane receptors on the cell surface that detect
physical stimuli and transfer the signal across the lipid bilayer. Most stimuli act
through one of about 20 families of receptor proteins, each coupled to distinct signal
transduction mechanisms [Pollard and Earnshaw, 2008]. Active receptors generate a
chemical signal inside the cell by interacting with one or more cytoplasmic proteins
6
2.1. Cellular signalling
and thereby transmit the signal into the cell. This transduction step converts one
type of signal (stimulus) into another signal (messenger) and commonly amplifies
the signal. The signal is then passed on to a series of complex biological interactions
and modification of intracellular signalling proteins that lead the signal to its final
destination within the cytoplasm or nucleus [Hancock, 2010]. The transfer and pro-
cessing of a signal can be accomplished through diverse biochemical reactions and
posttranslational modifications, such as protein (de)methylation and ubiquitination
and the dynamic formation (and dissociation) of protein complexes [Scott and Paw-
son, 2009]. (De)Phosphorylation is the most common posttranslational modification
of proteins and regulates the activity of one or more proteins along most signalling
pathways [Pollard and Earnshaw, 2008]. In this case, regulation is achieved by the
activity of a protein kinase (addition of a phosphate) or phosphatase (removal of
a phosphate). In a last step, the signal arrives at its final destination within the
cytoplasm or nucleus, where the signalling molecule may interact with a cytoskeletal
protein, a metabolic enzyme or a gene regulatory protein. This interaction leads to
the appropriate cellular response and hence results in a change of behaviour of the
cell [Alberts et al., 2002]. Depending on the initial signal and the signalling pathway,
the cell thus alters its shape or movement, metabolism or gene expression.
Signalling pathways regulate virtually all cellular processes. Understanding sig-
nalling pathways, however, is challenging [Pollard and Earnshaw, 2008]. First, cells
employ hundreds of distinct signalling pathways, involving hundreds and thousands
of different proteins. Second, most pathways include positive or negative feedback
loops allowing for complex responses, such as sigmoidal and hysteretic switches,
transient responses and oscillators [Tyson et al., 2003]. Third, few signal trans-
duction mechanisms utilize simple linear pathways from a stimulus to a change in
behaviour. Rather most pathways branch and converge multiple times and signals
propagate through a tangled network of interconnecting proteins and cascades rather
than through independent linear routes, making it difficult to predict how informa-
tion flows through a system [Kholodenko et al., 2010]. Finally, the response of some
pathways depends on both, the duration and the amplitude of the stimulus.
Wnt signalling is among the handful of key signalling pathways that play roles in
almost all aspects of metazoan biology. It is an ancient system that has been highly
conserved during evolution throughout the animal kingdom. It regulates normal
embryonic development, tissue homeostasis and regeneration. Aberrations of Wnt
signalling cause various diseases, including cancer. Next, I give an introduction to
Wnt signalling, its key players and its role in development and disease.
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2.2. Wnt signalling in development and disease
In 1982, Varmus and Nusse reported the identification of a tumour virus that in-
duced mammary gland tumours in mice by activating the expression of a hitherto
unknown proto-oncogene that they named Int-1 (Integration-1) [Klaus and Birch-
meier, 2008, Nusse and Varmus, 1982]. Independently, a Drosophila melanogaster
mutant lacking wings was described by Sharma and Chopra [1976] and the respon-
sible fly gene was hence named wingless (wg). Subsequently, Drosophila wg was
also shown to control segment polarity during larval development [Nu¨sslein-Volhard
and Wieschaus, 1980]. Based on protein sequence homology, Rijsewijk et al. [1987]
showed that Int-1 and wg were homologs. Accordingly, the name Wnt is derived
from a combination of both, Wg and Int-1.
Currently, three different Wnt pathways are distinguished: the canonical Wnt/β-
catenin cascade, the noncanonical planar cell polarity (PCP) pathway and the non-
canonical Wnt/Ca2+ pathway. Of these three, the canonical Wnt/β-catenin is best
understood and subject of this thesis. For comprehensive overviews to the other
Wnt signalling pathways, the reader is referred to [Katoh, 2005] and [Kohn and
Moon, 2005].
In the following, I introduce the key players of canonical Wnt/β-catenin signalling,
i.e. Wnt proteins, β-catenin and the destruction complex. Subsequently, I discuss
the pathway and its role in development and disease.
2.2.1. Wnt proteins
The mammalian Wnts compromise a large highly conserved family of 19 secreted,
glycosylated and lipidated protein ligands that have crucial roles in the regulation
of diverse processes such as embryonic induction, generation of cell polarity and the
specification of cell fate [Anastas and Moon, 2012, Logan and Nusse, 2004]. Wnts
are defined by their amino acid sequence rather than by functional properties [Lo-
gan and Nusse, 2004]. Wnt proteins are characterised by a high number (23-24) of
conserved cysteine residues and have an approximate molecular weight of 40 kDa
[Miller, 2002].
After synthesis, Wnts are escorted to the plasma membrane for secretion. The pic-
ture of Wnt secretion though is incomplete, with diverse proposed mechanisms that
are yet a matter of conjecture (see [Coudreuse and Korswagen, 2007] for a recent
review). After secretion, Wnt bind lipoproteins in the extracellular environment.
Wnt proteins can signal to the cell that produced them (i.e. autocrine signalling)
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and to other cells (i.e. paracrine signalling). They function as morphogens that are
capable of both, short- and long-range signalling (reviewed in [Logan and Nusse,
2004]). However, it is unclear how the long-range gradients are generated.
Binding of extracellular Wnt proteins to the membrane receptors Frizzled (Frz)
[Bhanot et al., 1996] and LDL-related protein (LRP5/6) [Mao et al., 2001] initiates
the Wnt pathway. In Wnt/β-catenin signalling, Wnts strictly control the phospho-
rylation, degradation and regulation of β-catenin [MacDonald et al., 2009].
2.2.2. The key signalling protein: β-catenin
The protein β-catenin has a molecular weight of ∼ 90 kDa and is encoded by a single
gene in most animals and humans. The β-catenin protein is a truly dual function
protein and a pivot between cell adhesion and Wnt signalling, as it contains bind-
ing sites for cadherins, TCF, APC and Axin [Valenta et al., 2012]. Initially, it was
discovered for its role in cell adhesion [Kemler, 1993]. As a structural component
of adherens junctions, it promotes cell adhesion by binding to the cytoplasmic do-
mains of classical cadherins and linking cadherin to the actin cytoskeleton through
the adaptor protein α-catenin [Bienz, 2005, Johnson et al., 2009]. Within this com-
plex, β-catenin is immobile and does not influence Wnt signalling. In contrast, the
signalling function of β-catenin is conferred by a soluble cytoplasmic pool that is
highly unstable in the absence of a Wnt signal [Bienz, 2005]. It is the key effector in
the canonical Wnt signalling pathway [Bienz, 2005, Kikuchi, 2000]. In the nucleus, it
forms a complex with transcription factors from the LEF/TCF (Lymphoid enhancer
factor 1/T-cell factor) family, which initiates target gene expression [Behrens et al.,
1996, Mosimann et al., 2009]. The principal regulatory mechanism that controls the
levels of soluble β-catenin is the activity of the so-called destruction complex.
2.2.3. The destruction complex
The destruction complex is a dynamic multiprotein assembly. Minimally, it con-
sists of the scaffolding proteins Axin and APC, and the kinase GSK3 [Doble and
Woodgett, 2003, Hart et al., 1998, Kishida et al., 1998, Yost et al., 1996]. As these
proteins counteract β-catenin, I refer to them as β-catenin antagonists (see Figure
2.2). Apart from the three mentioned proteins, the destruction complex also in-
cludes another kinase, namely casein kinase 1 (CK1) [Liu et al., 2002], as well as
the E3-uniquitin ligase β-Trcp. For a very detailed recent review on the destruction
complex, see [Stamos and Weis, 2012]. In this thesis however, the focus lies on the
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core components Axin, APC and GSK3.
Axin has a molecular weight of ∼ 110 kDa [Chia and Costantini, 2005]. In ver-
tebrates, there exist two isoforms, Axin and Axin2/Conductin. Axin is a largely
unstructured, flexible protein that contains CK1, GSK3 and β-catenin binding sites
[Stamos and Weis, 2012]. Axin is the central phosphorylation scaffold of the Wnt/β-
catenin pathway, meaning that phosphorylation of β-catenin is greatly enhanced by
the presence of Axin [Stamos and Weis, 2012]. It contains binding sites for all the
complex components, and also a binding site for β-catenin.
APC is short for Adenomatous polyposis coli. It is a large∼ 310 kDa multifunctional
protein [Brocardo and Henderson, 2008] with several structural domains [Kikuchi,
2000]. It is an important tumour suppressor in the colon. APC mutations occur in
80% of all colon cancers [Roberts et al., 2012]. It is highly conserved and essential
for cell survival. APC is a highly mobile protein with multiple destinations in the
cell, with multiple roles that include the regulation of directed cell migration, apop-
tosis and DNA repair [Brocardo and Henderson, 2008]. Apart from the destruction
complex, APC can associate with β-catenin itself [Bienz, 2002].
The ability of APC to interact with β-catenin has been demonstrated to be enhanced
by phosphorylation of APC in vitro [Rubinfeld et al., 1996]. Seo and Jho [2007] pro-
posed that accumulation of β-catenin induces phosphorylation of APC and that
phosphorylated APC in turn retains β-catenin. Moreover, Sierra et al. [2006] con-
cluded from their experiments that β-catenin cannot bind unphosphorylated APC
efficiently and that CK1 phosphorylation of APC might induce high-affinity bind-
ing to β-catenin and even trigger its dissociation from LEF/TCF. Phosphorylated
APC and Axin bind the same surface of β-catenin and therefore directly compete
for β-catenin binding.
GSK3 is short for Glycogen synthase kinase 3. It was originally identified in the con-
text of regulation of the glycogen metabolism [Embi et al., 1980], though it is now
known to regulate many other cellular processes, including protein synthesis, gene
expression and protein degradation [Caspi et al., 2008]. It is highly conserved from
yeast to mammals [Wu and Pan, 2010]. Mammals express two isoforms, GSK3α
(∼51 kDa) and GSK3β (∼47 kDa). The activity of GSK3 itself is regulated by
phosphorylation-dephosphorylation, with phosphorylation being inhibitory [Sugden
et al., 2008]. It is emerging as an important therapeutic target in a variety of
pathologies, including diabetes, neurogenerative disorders and tumorigenesis [Cohen
and Goedert, 2004, Doble and Woodgett, 2003, Wu and Pan, 2010]. It is predomi-
nantly located in the cytosol, but is also present in nuclei and mitochondria [Bijur
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and Jope, 2003]. GSK3 has been reported to phosphorylate a large number of sub-
strates (at least 40 [Wu and Pan, 2010]). It preferentially phosphorylates substrates
like β-catenin residues in a “relay” fashion. For this, a priming phosphorylation on
a Serine/Threonin (Ser/Thr) residue is catalysed by a protein kinase distinct from
GSK3 [Doble and Woodgett, 2003, Sugden et al., 2008]. In case of β-catenin, the
priming phosphorylation is conducted by the kinase CK1 on Ser45. Subsequently,
GSK3 sequentially phosphorylates β-catenin at the residues Thr41, Ser37 and Ser33
[Wu and Pan, 2010].
2.2.4. The Wnt/β-catenin signalling pathway
The canonical Wnt/β-catenin pathway has been studied extensively, since it has
been experimentally proven to play a crucial role in several developmental pro-
cesses, including synaptic differentiation in neurogenesis [Cadigan and Nusse, 1997],
neuronal connectivity [Ciani and Salinas, 2005] and stem cell control [Nusse, 2008].
It is known to regulate cell fate determination, cell proliferation and tissue home-
ostasis [Baron and Kneissel, 2013, Cadigan and Peifer, 2009, Clevers and Nusse,
2012, Huang and He, 2008, Logan and Nusse, 2004, Nusse, 2008, van Ameron-
gen and Nusse, 2009]. Mutations and deregulated expression of components of
the pathway underlie a wide range of pathologies, including various types of can-
cer [Anastas and Moon, 2012, Carethers, 2009, Klaus and Birchmeier, 2008, Moon
et al., 2004, Reya and Clevers, 2005], bone defects, arthritis, schizophrenia [Clevers,
2006] as well as neurodegenerative diseases such as Alzheimer’s and Parkinson’s
disease [Inestrosa, 2000, Inestrosa and Arenas, 2010]. Wnts are also likely to con-
tribute in the future to improve stem/precursor cell replacement therapy approaches
to Parkinson’s disease [Castelo-Branco and Arenas, 2006]. The Wnt/β-catenin
pathway is subject to a multiplicity of reviews (see [MacDonald et al., 2009] for
a well-written, detailed example). For a complete list of reviews and for up-to-
date information on the pathway, the reader is also referred to the Wnt Homepage
(http://www.stanford.edu/group/nusselab/cgi-bin/wnt/).
The protein β-catenin is the central signalling molecule of the canonical Wnt/β-
catenin signalling pathway [Kikuchi, 2000]. In the nucleus, it forms a complex with
transcription factors from the LEF/TCF family (see Section 2.2.2), which initiates
target gene expression [Behrens et al., 1996, Mosimann et al., 2009]. The principal
regulatory mechanism that controls the nuclear accumulation of β-catenin is the
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Figure 2.2.: The Wnt/β-catenin signalling pathway. Left: The Wnt-off state. Cytoplas-
mic degradation keeps β-catenin levels low. Right: The Wnt-on state. The destruction
complex is inhibited in the cytoplasm. In the nucleus, the interaction of β-catenin with
TCF induces target gene expression. See text for details.
activity of the destruction complex. Basically, Wnt signalling functions in either
the on- or off-mode, depending on whether extracellular Wnt ligands (see Section
2.2.1) are present or not.
In the absence of a Wnt stimulus (the off-state; see Figure 2.2, left), β-catenin
forms a complex with Axin, APC, GSK3 and CK1 (i.e. the destruction complex,
see Section 2.2.3), and is phosphorylated by CK1 and subsequently by GSK3. Af-
terwards, phosphorylated β-catenin is recognised by the ubiquitin ligase β-Trcp,
which targets β-catenin for proteasomal degradation. It is then released from the
destruction complex and rapidly degraded by a large protein complex, called the
proteasome [Aberle et al., 1997]. Thus, in the off-state β-catenin levels are kept low.
In the nucleus, LEF/TCF is maintained in a repressed state by association with
inhibitors such as Groucho.
Upon binding of Wnt ligands to their receptors Frz [Bhanot et al., 1996] and LRP5/6
[Mao et al., 2001], the pathway is activated (the on-state; see Figure 2.2, right). In
the presence of an extracellular Wnt stimulus, a receptor complex forms between
Frz and LRP, resulting in signal transmission into the cell. The first intracellular
signalling protein to be activated is Dishevelled (Dsh), which is recruited to the
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receptor complex, where it binds Frz. This then leads to LRP phosphorylation and
Axin recruitment to the receptor complex (see [Niehrs, 2012] for a review on Wnt
receptor signalling). Therefore, in the Wnt-on state, the activity of the destruction
complex in the cytoplasm is disrupted, leading to destruction complex dissociation.
This induces accumulation of non-phosphorylated β-catenin in the cytoplasm. It
then translocates into the nucleus and subsequently accumulates there. In the nu-
cleus, β-catenin displaces Groucho and then serves as a coactivator for TCF to
activate Wnt target gene expression [Tolwinski and Wieschaus, 2004].
Currently, 123 genes are known to be target genes of Wnt/β-catenin signalling (for
details and updates, see the Wnt homepage provided and regularly updated by the
Nusse Lab (http://www.stanford.edu/group/nusselab/cgi-bin/wnt/). Fourteen of
these target genes – including Frz, LRP, TCF and Axin2 – are components of the
Wnt pathway and therefore provide positive or negative feedback loops.
Since the discovery of the Wnt gene in 1982 [Nusse and Varmus, 1982], Wnt/β-
catenin signalling has cemented its role as a key regulatory system in biology. How-
ever, even after 30 years of intense study, there are still various mechanisms of the
Wnt signalling cascade that remain unclear (see [Clevers and Nusse, 2012], who
highlighted ten of those questions, including the subcellular location of Wnt sig-
nalling events and the nuclear translocation of stabilised β-catenin), particularly
with regard to its role in human disease [Chien et al., 2009]. An important aspect
that has recently come into focus of research is the fact that not only β-catenin as a
transcriptional cofactor is able to translocate into and out of the nucleus. A surpris-
ingly high number of cytoplasmic Wnt regulators are shuttling proteins that have
been proven to reside in both, cytoplasm and nucleus, where they may, directly or
indirectly, interact with β-catenin and therefore influence its transcriptional activity
[Willert and Jones, 2006]. This holds true especially for the β-catenin antagonists
we consider here: APC [Neufeld et al., 2000, Rosin-Arbesfeld et al., 2000], Axin
[Cong and Varmus, 2004, Wiechens et al., 2004] and the kinase GSK3 [Bijur and
Jope, 2003, Caspi et al., 2008, Franca-Koh et al., 2002]. The question why they
do so is still discussed controversially in the community and forms the focus of this
thesis. In the next sections, I give a short introduction to intracellular transport
and nucleo-cytoplasmic shuttling mechanisms. Afterwards, I summarise experimen-
tally derived hypotheses on the shuttling and nuclear functions of β-catenin and its
antagonists APC, Axin and GSK3.
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2.3. Intracellular transport
A typical eukaryotic cell contains many thousands of different proteins, almost all
of which are synthesised in the cytoplasm [Friedman, 2008]. These proteins include
molecules intended to function in one of the many organelles of the cell, or the
plasma membrane, or intended for secretion into extracellular space (such as the
Wnt proteins, discussed in Section 2.2.1.) There are several mechanisms by which
specific proteins are directed to their final destination [Friedman, 2008]. Intracel-
lular transport is most commonly described as either diffusive or directed by other
cellular molecules. The transmission of information over intracellular distances of
more than a few micrometres requires facilitated transport mechanisms, including
movement of phosphorylated kinases on scaffolding proteins and endosomes driven
by molecular motors [Kholodenko, 2006].
The contents of the eukaryotic nucleus are separated from the cytoplasm by the
nuclear envelope. Transport into or out of the nucleus occurs through bidirectional
aqueous pores in the nuclear membrane [Strambio-De-Castilla et al., 2010, Zilman
et al., 2007]. There are several thousand such nuclear pore complexes (NPCs) in the
nuclear membrane of a typical cell [Friedman, 2008]. The process of actual translo-
cation across the NPC generally occurs either by diffusion or facilitated transport
[Xu and Massague´, 2004]. The radius of the pores is found to be 4-5 nm [Friedman,
2008], therefore small molecules of this size and smaller ( . 50 kDa [Kopito and
Elbaum, 2007, Macara, 2001]) can exchange freely between the nuclear lumen and
the cytoplasm. Large macromolecules are transported through the NPC if they con-
tain a particular amino acid sequence, called the nuclear localisation signal (NLS)
(for import) or nuclear export signal (NES) (for export)[Friedman, 2008, Zilman
et al., 2007]. These sequences are required for nucleo-cytoplasmic transport medi-
ated by importin/exportin receptors, such as importin-β and Chromosome region
maintenance 1 (CRM1), respectively [Xu and Massague´, 2004].
2.4. Nucleo-cytoplasmic shuttling of Wnt pathway
components
Unlike NLS-mediated import and despite a molecular weight of ∼ 90 kDa, β-catenin
enters the nucleus independently of the importin receptor. Instead, it can interact
directly with the NPC and can translocate on its own [Fagotto et al., 1998, Yokoya
et al., 1999]. This is possible because, like importin-β, β-catenin contains several
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HEAT-like repeats, which are protein domains that are both, necessary and suf-
ficient for nuclear import [Xu and Massague´, 2004]. Its nuclear export is “rather
nebulous and somewhat controversial” [Sta¨deli et al., 2006]. On the one hand, there
is experimental evidence that β-catenin is exported out of the nucleus on its own,
using interactions with the nucleoporins to pass through the NPC independently of
the CRM1 exportin pathway [Eleftheriou et al., 2001, Wiechens and Fagotto, 2001].
On the other hand, it has been proposed to bind to APC or Axin to exit the nucleus
[Cong and Varmus, 2004, Henderson, 2000, Neufeld et al., 2000, Rosin-Arbesfeld
et al., 2000, 2003, Wiechens et al., 2004].
Axin can interact directly with the CRM1 receptor, although via non-classical NES
sequences [Wiechens et al., 2004]. Although cytoplasmic at steady state, Axin shut-
tles in fact into and out of the nucleus, where it may also have yet unknown functions
[Wiechens et al., 2004].
APC exhibits at least two NES interacting with the CRM1 nuclear export factor
and has been proven to shuttle between cytoplasm and nucleus [Neufeld et al., 2000,
Rosin-Arbesfeld et al., 2000], but the functional relevance of this is still controversial
[Bienz, 2002, Brocardo and Henderson, 2008, Henderson and Fagotto, 2002]. It was
proposed that the nuclear export of APC controls the level and hence the transcrip-
tional activity of nuclear β-catenin [Henderson, 2000, Rosin-Arbesfeld et al., 2003].
Most recent findings, however, indicate that APC and Axin (and also Axin2) enrich
β-catenin in the cytoplasm, but do not accelerate the nucleo-cytoplasmic shuttling
of β-catenin, i.e. increases the rate of β-catenin nuclear import or export [Krieghoff
et al., 2006]. From their results, Krieghoff et al. [2006] concluded that β-catenin
antagonists, such as APC, mainly regulate β-catenin subcellular localisation by re-
taining it in the compartment in which they are localised, rather than by active
transport into or out of the nucleus.
The kinase GSK3 exhibits a bipartite NLS, which was found to be both necessary
and sufficient for nuclear localisation. GSK3 is highly active in the nucleus [Bijur
and Jope, 2003], where it can bind the protein FRAT and be exported in a CRM1-
dependent fashion [Franca-Koh et al., 2002]. It was proven that GSK3 has a nuclear
function in downregulating the activity of β-catenin [Caspi et al., 2008].
The fact that GSK3 can enter the nucleus and might regulate the levels of Wnt sig-
nalling prompts to re-evaluate the current view of the pathway [Caspi et al., 2008].
Moreover, as GSK3, Axin and APC all appear in the nucleus and might have a
nuclear function in regulating the Wnt signal, it is conceivable that the β-catenin
degradation complex is assembled in the nucleus [Caspi et al., 2008].
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To sum up, several approaches have been followed in order to understand the func-
tional role of nucleo-cytoplasmic shuttling of Wnt pathway components, in particular
APC, Axin and GSK3 as β-catenin antagonists. Different experiments resulted in
different hypotheses. However, the functional relevance of antagonist shuttling in
the Wnt/β-catenin pathway is yet to be determined.
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Kinetic modelling of biochemical reactions has a long history. The Michaelis-Menten
model for the rate of irreversible reactions in enzyme kinetics, for example, is a
milestone in biochemistry and was developed in the early 20th century. Other early
milestones include the work of Hodgkin and Huxley [1952], with their groundbreak-
ing mathematical reconstruction of the nerve impulse, and the work of Turing [1952]
on the chemical basis of morphogenesis, who reproduced spatial patterns which are
ubiquitous in nature, e.g. on sea shells or animal coats, with a simple reaction-
diffusion model. The term ‘Systems biology’ was coined by Mesarovic´ [1968] and
is an interdisciplinary approach combining mathematical modelling and quantita-
tive cell biology [Klipp, 2009]. Systems biology models are often based on well-
established physical laws, e.g. the thermodynamics of chemical reactions [Klipp
et al., 2009]. Since the 1990s, modelling has emerged as a tool to decipher the
dynamics of biochemical reaction networks and to provide insights into the complex
relationships between cellular stimuli and the corresponding responses [Kholodenko,
2006].
In this chapter, I give an introduction to mathematical modelling of biochemical
networks to provide the theoretical background for the models I derive and investi-
gate in the following chapters. I start with defining a model in Section 3.1, where
I also explain why modelling is useful. I then present different approaches to ma-
thematical modelling in Section 3.2. In particular, I focus on spatial aspects and
on the central question of how to choose an appropriate modelling approach for my
research questions. Subsequently, I present the modelling framework I decided to
use in this thesis. To this end, I show how to model biochemical networks with ordi-
nary differential equations (ODEs) in Section 3.3. Finally, in Section 3.4, I present
relevant techniques for the analysis of models, such as stability analysis and sensi-
tivity analysis. For an extensive discussion of mathematical modelling applied to
biological systems, the reader is referred to the textbook by Klipp et al. [2009].
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3.1. The purpose of modelling
In a broad sense, a model is an abstract representation of objects or processes that
explains features of these objects or processes [Klipp et al., 2009]. A biochemi-
cal reaction network is often represented by a graphical sketch showing proteins as
nodes and reactions as arrows. The interactions and dynamics of its components
can be described using the language of mathematics. As the interactions between
the objects and processes of such a dynamical system are often highly nonlinear, the
system can exhibit complex – often counter-intuitive – behaviour. As such, a ma-
thematical model is a tool that helps to overcome the linearity of Human thinking
[Do¨rner, 1980].
The quantities of a mathematical model can be classified as variables, parameters
and constants. A constant is a quantity with a fixed value, such as Avogadro’s
number which is the numbers of molecules per mole. Parameters include reaction
rate constants or total protein concentrations. Their values are time independent,
but can depend on experimental conditions and may change, for example, due to
different cellular compositions or different cell types. Variables (in signalling often
species or substances) are quantities which values change over time and/or space.
A subset of all variables, the state variables, describe the system’s behaviour com-
pletely. They are linearly independent of each other and form a basis of the state
space. Therefore each of them is necessary to define the current state of the system.
Models represent only specific aspects of the reality. The intention of modelling is
to answer a particular question. Modelling is thus a subjective and selective proce-
dure. It needs to make specific statements about the system of interest. In case of
systems biology, these statements are justified by either experiments and biochem-
ical knowledge, or by mere extrapolation from other systems [Klipp et al., 2009].
Typically, systems biology projects on cellular signalling are characterised by close
integration of experiments with mathematical models realised through an iterative
cycle of quantitative cell biology, computational modelling, parameter estimation,
model predictions and experimental validation [Becker et al., 2010, Blu¨thgen et al.,
2009, Chen et al., 2009, Lai et al., 2012, Lange et al., 2012, Rateitschak et al., 2010,
Schilling et al., 2009, Schmidt et al., 2012]. Simulation is a simple but powerful tool
for studying a model’s behaviour and guiding experiments [Aldridge et al., 2006a].
It allows to compare time-dependent concentrations of key species over a range
of concentrations, network topologies and rate parameters. Model simulations are
cheap compared to wet-lab experiments. They can be repeated often and for many
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different conditions. Moreover, modelling also offers benefits other than prediction
[Epstein, 2008]. It is even a powerful tool without the availability of experimental
data. It highlights gaps of knowledge or understanding and can provide insights
into principal mechanisms. Modelling drives conceptual clarification. Examples in-
clude the discovery of recurring network motifs or fundamental design principles
of signalling pathways, such as feedback and feedforward loops [Mangan and Alon,
2003, Markevich et al., 2004, Tyson et al., 2003], thresholds in transient dynam-
ics [Rateitschak and Wolkenhauer, 2010], as well as defined measures to quantify
signalling time, signal duration and signal amplitude [Heinrich et al., 2002].
3.2. Discussion of selected spatio-temporal modelling
approaches
Cells and organisms show complex spatial structures, which are vital for the pro-
cesses of life [Klipp et al., 2009]. Various modelling approaches have been successfully
used to address specific questions about biochemical systems. The range of prob-
lems that can be tackled is growing steadily and the modelling approaches differ
in their modularity and mathematical implementation [Tomlin and Axelrod, 2007].
The ‘correct’, or rather appropriate mathematical form of a dynamical model de-
pends on many different practical and experimental considerations, such as the goal
or purpose of the modelling effort, the available data, the computational power or
personal preferences [Aldridge et al., 2006a, Voit et al., 2008].
The central question I focus on in this section is how to describe the spatio-temporal
distribution of species or substances in a model, which affects the interactions be-
tween these species to a large extent. There exist a large variety of different types
of spatio-temporal models, which exhibit different advantages and disadvantages.
Ultimately, to choose a suitable modelling approach, one needs to balance com-
putational cost against the biological realism. In the following, I present selected
approaches for spatio-temporal modelling, in order to find a suitable approach for
my research questions. I then discuss which approach I have chosen, and why.
The interactions and temporal evolution of molecular species in a model can ei-
ther be represented individually (microscopic scale) or as a population (macroscopic
scale). Signalling pathways mainly describe processes that contain a large number
of molecules. In this case, a population-based representation of species has the ad-
vantage of low computational costs. Models for signalling pathways can be loosely
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grouped as follows [Klipp and Liebermeister, 2006]: i) deterministic (with defined
states in the future) or probabilistic (stochastic processes); ii) discrete or continuous
(with respect to time or component abundances, e.g. molecule numbers or concen-
trations); and iii) they may or may not account for space. Currently, in most models,
biochemical reactions are described in a deterministic, continuous manner by rate
equations for concentrations of substances and complexes using a system of ODEs
[Aldridge et al., 2006a, Kholodenko et al., 2010]. An ODE denotes an equation
in which differentiation occurs with respect to only a single independent variable,
mostly time [Kholodenko, 2006]. ODE modelling is population-based and assumes
a spatial homogeneity, i.e. a well-stirred medium without any barriers [Klipp et al.,
2009]. It furthermore assumes that all molecules move freely and independently
and that diffusion is much faster than chemical reactions. Inhomogeneities will thus
rapidly disappear and the substances can hence be described by the concentrations
averaged over a cell.
If molecules, however, are not homogeneously distributed, e.g. because membranes
hamper free movement, then spatial location and structure have to be taken into
account. In the deterministic framework, the spatio-temporal distribution of species
can be described indirectly by distinguishing different compartments or directly, by
describing dynamics in continuous or discrete space [Bittig and Uhrmacher, 2010].
In compartmental models, each species is allowed to be located in one or more com-
partments and to move between them through elementary reactions [Aldridge et al.,
2006a, Bittig and Uhrmacher, 2010]. There are two fundamental assumptions for
the compartmentalised ODE formalism [Aldridge et al., 2006a, Takahashi et al.,
2005]: First, within a homogeneous compartment, the concentration of each species
is high and transport is essentially instantaneous. Second, the transport between
compartments is slower and modelled by transport reactions.
If these assumptions are not satisfied, then it is necessary to model changes in
species concentrations explicitly with respect to space. In a population-based ap-
proach, partial differential equations (PDEs) are typically used to account for space.
PDEs contain partial derivatives with respect to two or more independent (in this
case, spatial) variables [Kholodenko, 2006]. PDE models assume that concentrations
are smooth functions in space, which only holds on a spatial scale much larger than
the average distance between molecules and if inhomogeneities of the spatial struc-
ture are neglected. In practice, solving PDEs is usually computational demanding.
By discretising space, however, spatial structures can be taken into account in a
population-based approach without increasing computational costs (e.g. by using
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Cellular Automata) [Kossow et al., 2013].
If a substance is present in small amounts, an individual-based representation of
molecules and reaction events is often more suitable to yield low computational
costs. In systems with small amounts of individuals, stochastic effects due to ther-
mal movement and chemical reactions become relevant [Takahashi et al., 2005]. In
this case, the behaviour of individual molecules have to be simulated stochastically.
There are several approaches available, most of which are based on Brownian dy-
namics [Takahashi et al., 2005] or the Gillespie algorithm [Gillespie, 1977, Klipp and
Liebermeister, 2006]. To date, a remaining challenge in the field of stochastic spatio-
temporal modelling of cellular systems is the lack of standard analysis methods and
therefore very limited availability of analytical tools, as most results are obtained
using simulations.
Within this thesis, I model the Wnt/β-catenin pathway as a biochemical reac-
tion network including two cellular compartments, cytoplasm and nucleus. These
models allow for nucleo-cytoplasmic shuttling of β-catenin and its antagonists, and
for protein complex formation of β-catenin with APC and with the destruction
complex in the cytoplasm and nucleus, respectively. Within each compartment, I
do not consider spatial dimension and assume a well-mixed, homogeneous reaction
medium. Transport between the compartments is assumed to be slower than the
movement within the compartments and modelled as either diffusion-like motion or
active transport by transporter proteins. Therefore, the compartmentalised ODE
formalism as a deterministic population-based modelling approach offers the most
convenient way to represent the dynamics of the variables within my models. In
addition, the ODE modelling approach has the advantage that there exists a large
variety of available methods, tools and software from dynamical systems theory to
analyse the behaviour of the system. In the next section, I give an introduction to
the mathematical structure of a system of coupled ODEs and the methods I use to
investigate such a system.
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3.3. The mathematical structure of an ODE model
The temporal evolution of a biochemical network in a deterministic approach can
be described by a set of (coupled) ODEs [Klipp et al., 2009]. A general ODE system
can be written in the form
dXi
dt
≡ X˙i = fi(X1, ..., XN , k1, ..., kM) i = 1, ..., N, (3.1)
where X1, ..., XN is a set of variables and t is time. The temporal evolution of
the system is determined by the functions f1, ..., fN depending on the parameters
k1, ..., kM and the variables X1, ..., XN . In this notation, N is the dimension of the
state space, whereas M is the dimension of the parameter space. The left hand side
of the ODE is the time derivative of a species concentration. If the right hand side
of the ODEs is not explicitly dependent on time, the system is called autonomous,
which is generally the case in biochemical modelling.
In most ODE models, the right hand side of Equation (3.1) is the algebraic sum of
reaction rates for the production and consumption of the involved species, i.e. pro-
teins and complexes:
X˙i =
r
j=1
mijνj(X1, ..., XN , k1, ..., kM) i = 1, ..., N, (3.2)
where N is the number of biochemical species with the concentrationsXi and r is the
number of reactions with the rates νj and the stoichiometric coefficientmij. Depend-
ing on experimental information, the individual reaction rates can be described by
sophisticated kinetic laws. However, most commonly mass action kinetics are used
[Klipp and Liebermeister, 2006], which is an empirical law stating that the rate of a
reaction is proportional to the concentration of the reacting species [Aldridge et al.,
2006a]. A biochemical transformation of the form X1 + X2
k1− ==−
k2
X3 is thereby
represented by the reaction rate
ν = k1X1X2 − k2X3, (3.3)
described with forward and reverse reaction rate constants k1 and k2, respectively.
The rate constant k2 of monomolecular reactions has the dimension s
−1, whereas
the rate constant k1 for bimolecular reaction has the dimension M
−1s−1 (where M
equals mol per litre).
Differential equations can be substituted by time-independent algebraic relations,
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resulting in a smaller model with more complex rate terms [Aldridge et al., 2006a]. A
common example of an algebraic substitution is replacing mass action kinetics with
the Michaelis-Menten equation, which approximates the reaction rate for enzyme-
catalysed reactions of a substrate S into a product P (S → P ) as follows:
ν =
vmaxS
kM + S
. (3.4)
The quantity vmax is the maximal rate. kM is the half-saturation constant and de-
notes the substrate concentration ensuring a half-maximal rate [Klipp and Lieber-
meister, 2006]. Note that this approach can only be applied if the concentration of
the substrate is in excess of the enzyme and the quasi-steady state assumption is
fulfilled [Millat et al., 2007]. This is only the case if elementary reactions produce
short-lived intermediates (like the enzyme-substrate complex) and the rate of for-
mation for an intermediate complex and its dissociation back into the reactants is
much faster than its conversion into products [Atkins and De Paula, 2002].
3.4. Methods and concepts chosen for model analysis
When the structure, the mathematical implementation and the parametrisation of
the model have been determined or estimated, mathematical exploration and analy-
sis begins. Simulations are a widely-used tool to study the model’s behaviour, as they
depict the temporal evolution of system variables. In the context of ODEs, model
simulation is performed by numerical integration. Other analysis tools relevant for
this thesis include stability and sensitivity analysis. In the following sections, I
present these tools and discuss how they are applicable to the study of steady states
and transient dynamics, respectively.
3.4.1. Steady states and their stability
The concept of steady states is important for the modelling of all dynamical systems.
In dynamical systems theory, a system is characterised by its state, which equals a
snapshot of the system at a given time [Klipp et al., 2009]. The state of a system
is described by a set of variables (state variables). The set of all possible states is
the state space. Steady states (or stationary states or fixed points), in contrast to
transient dynamics (see Section 3.4.2), are determined by the fact that the values
of all state variables remain constant in time. Therefore, to study the steady states,
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those states in which the time derivatives vanish are considered:
dXi
dt
= 0. (3.5)
If a system is in steady state, it stays there, until an external perturbation occurs.
The asymptotic behaviour of dynamic systems, i.e. the behaviour after a sufficiently
long time, is often stationary. Other types of asymptotic behaviour are oscillatory
or chaotic regimes.
To investigate whether a steady state X∗ of an ODE system is (asymptotically)
stable, we have to consider small perturbations of the state variables. A linearisation
of the evolution equations (3.1) close to the steady state yields the Jacobian matrix.
The Jacobian is a real N ×N matrix with its coefficients being
Jij =
∂fi
∂Xj

X=X∗
i, j = 1, ..., N, (3.6)
where N is the dimension of the state space. These coefficients calculated at steady
state X∗. If all eigenvalues of the Jacobian have non-vanishing real parts the steady
state is called hyperbolic. A hyperbolic steady state is asymptotically stable if (and
only if) all eigenvalues of the Jacobian are negative. Transitions in the stability of
steady states occur if eigenvalues of the Jacobian cross the imaginary axis (leading
to at least one positive eigenvalue) in response to parameter variation. In parameter
space, these transition points are called bifurcation points. Crossing a bifurcation
point leads to a qualitative transition in state space, which corresponds to a change
in the asymptotic long term behaviour of the system. Such a transition is called a
bifurcation.
Stability and bifurcation analysis are of interest because they help to explain how a
network can switch between different states [Aldridge et al., 2006a]. These methods
are however restricted to the analysis of steady states.
3.4.2. Transient dynamics
Transient dynamics describe the transition from a state far away from a steady state
(e.g. some initial state of the system) into a steady state and the transition from one
steady state to another, respectively. In case of transient processes, other techniques
from dynamical systems theory than stability or bifurcation analysis are required
to determine how the output of a model will change over time (or time and space)
when initial conditions or parameter values change. These methods include the
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singular-perturbation theory and finite-time Lyapunov exponents [Aldridge et al.,
2006a,b], as well as defined measures to quantify key features of transient stimuli,
such as the time, rate and duration of signalling and the amplitude of the signal
output [Heinrich et al., 2002, Millat et al., 2008].
3.4.3. Sensitivity analysis
In order to study the influence of small perturbations on a system’s behaviour and
thereby account for the robustness of the system, one widely used tool is sensitivity
analysis. It is a powerful method for systematically determining which concen-
trations and rate constants in a model have the biggest influence on the overall
behaviour [Aldridge et al., 2006a]. In addition to revealing key parameters in a
network, sensitivity analysis is valuable in ascertaining which parameters should be
in the focus of direct measurements or experimental perturbations. Insensitivity of
a model to parameter variation or perturbations is often equated with robustness.
Depending on the strategies used for perturbing the model parameters, sensitivity
analysis can be classified into two types: local and global sensitivity analysis. Local
sensitivity analysis investigates sensitivities of the model variables with respect to
particular points in parameter space, whereas global sensitivity uses the full ranges
of parameter space and addresses the global behaviour of model parameters using
statistical methods [Satelli et al., 2000]. In the following, I focus on local sensitivity
analysis.
For quantifying the effects of the perturbations, so-called control coefficients (also
known as sensitivities or response coefficients) are calculated. Originally, they were
proposed for quantifying control in metabolic networks and are nowadays a stan-
dard quantitative measure in sensitivity analysis [Heinrich and Schuster, 1996], not
only in systems biology. Control coefficients describe the relative response of the
concentration of a given compound (or state variable) Xi with respect to a relative
perturbation of the parameter kj and are defined by
C(Xi(t), kj) =

kj
Xi
∆Xi
∆kj

∆kj→0
=
kj
Xi
∂Xi
∂kj
. (3.7)
Note that the analysis is restricted to small perturbations of the reference value only,
as the relations between steady state variables and kinetic parameters are usually
nonlinear. For C(Xi(t), kj) = 0, a perturbation of the parameter kj has no influence
on the model variable Xi at time point t at all, which is thus most robust. The larger
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the value of C(Xi(t), kj), the higher the influence of the parameter perturbation.
In steady state, the concentration control coefficients fulfil the summation theorem
r
j=1
C
X∗i
νj = 0, (3.8)
for any steady state concentration X∗i . Again, r is the number of reactions rates ν.
Control coefficients can also be calculated for finite times to cover time-dependent
response coefficients as described by Ingalls and Sauro [2003] and Hornberg et al.
[2005]. Aside from control coefficients for signalling, characteristics such as maxi-
mum amplitude or mean signal time of output signals have been defined [Reijenga
et al., 2002], and spatial processes such as diffusion can be incorporated [Peletier
et al., 2003], as summarised by Klipp and Liebermeister [2006].
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pathway
In the last decade, several quantitative and qualitative mathematical models have
been developed to describe the Wnt/β-catenin pathway in order to gain deeper
insight into its functioning in time and space. Kofahl and Wolf [2010] have published
a first review on mathematical modelling of Wnt/β-catenin signalling, providing an
overview (including a timeline) of the models published from 2003 to 2010. The
models focus on different aspects of the Wnt pathway and describe it on different
scales, ranging from subcellular and biochemical to cellular and tissue scale. At the
biochemical level, there are detailed models of the core canonical pathway and its
crosstalk with other pathways [Cho et al., 2006, Kim et al., 2007, Kogan et al., 2012,
Kru¨ger and Heinrich, 2004, Lee et al., 2003, Wawra et al., 2007]. Cellular models
consider cell-cell interactions [Basan et al., 2010, Shin et al., 2010, van Leeuwen et al.,
2007] and tissue level models describe multicellular systems, investigating how Wnt
signalling regulates cellular decision-making and the development and maintenance
within multicellular systems. The latter also allow for multiscale models that couple
cellular and tissue behaviour with subcellular processes [Ramis-Conde et al., 2008,
Van Leeuwen et al., 2009].
In this chapter, I review previous modelling approaches of the Wnt pathway on
biochemical and subcellular level, as this work also takes biochemical reactions and
intracellular localization of Wnt pathway components into account. For an overview
on cellular and tissue scale models, the reader is referred to [Lloyd-Lewis et al.,
2013], who have recently published a comprehensive review on the understanding
the Wnt/β-catenin pathway through simulation and experiment, in which they have
classified the models according to the scale in which they are built. I start with the
“standard model” of Wnt signalling developed by Lee and colleagues [Lee et al., 2003]
and then present the models that have further analysed, extended and validated
the Lee Model. I conclude this chapter with summarising open questions of Wnt
pathway modelling on the biochemical subcellular level.
27
4. Modelling the Wnt/β-catenin pathway
Figure 4.1.: Reaction scheme of the Wnt/β-catenin pathway in the Lee Model (re-
produced from [Lee et al., 2003, Figure 1]). Protein complexes are denoted by the
names of their components. Phosphorylated components are marked by an asterisk.
Single-headed arrows characterise reactions taking place only in the indicated direction.
Double-headed arrows denote binding equilibria. The broken arrows indicated that the
components mediate, but do not participate stoichiometrically in the reaction scheme.
The irreversible reactions 2, 4, 5, 9-11 and 13 are unimolecular and the reactions 6, 7,
8, 16 and 17 are reversible binding steps.
4.1. A quantitative kinetic model of the pathway
The first quantitative model of the Wnt/β-catenin model was proposed by Lee et al.
[2003] (“Lee Model” in the following). It describes the interactions among the core
components of the pathway (namely Wnt, Dsh, β-catenin, APC, Axin, GSK3β
and TCF) excluding receptor dynamics. Figure 4.1 shows the reaction scheme the
model is based on. It incorporates the kinetics of protein-protein interactions, pro-
tein synthesis/degradation and β-catenin phosphorylation/dephosphorylation (solid
arrows). Besides, the model includes reactions that activate a certain process (bro-
ken arrows), e.g. the activation of Dsh by Wnt (step 1). The initial reference state
was defined on data from experiments using Xenopus egg extract, which is basi-
cally equivalent to well-stirred cytoplasm. Therefore the model proposed by Lee
et al. [2003] is purely temporal and does not take any spatial aspects into account.
Parameter values are chosen according to measurements and experimentally based
estimations combined with modelling assumptions. All species concentration (ex-
cept phosphorylated β-catenin) were determined experimentally using Western blot
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(or protein immunoblot), which is a widely accepted analytical technique used to
detect specific proteins in the given sample of tissue homogenate or extract. Addi-
tionally, fluxes and characteristic times have been measured to determine the kinetic
parameters describing the turnover of β-catenin and Axin (steps 11, 12, 13 and 14,
15, respectively). In contrast, the total concentrations of Dsh, GSK3β, APC and
TCF are assumed to be conserved, meaning that they stay constant over time, as the
corresponding biochemical experiments in Xenopus indicate a very slow turnover.
The mathematical model is expressed as a system of 15 coupled ODEs. The reac-
tions are described as follows: protein synthesis (arrows 12 and 14 in Figure 4.1) are
presented as a constant rate. Binding and dissociation are described using mass-
action kinetics, where unimolecular reactions (single-headed arrows) are assumed to
be irreversible and described by linear rate equations. Reversible binding (double-
headed arrows) is simplified by assuming that the binding step is very fast compared
to the dissociation step, such that the corresponding protein complexes are in rapid
equilibrium. Therefore, only the dissociation constant is considered in their kinetic
description. Using conservation equations and rapid equilibrium approximations,
the authors were able to reduce the model to 7 ODEs and 8 algebraic equations
[Kru¨ger and Heinrich, 2004, Lee et al., 2003].
The validated Lee Model predicted several unusual features of the Wnt pathway,
some of which were tested experimentally. A crucial observation was the low abun-
dance of Axin. The model explains the importance of Axin degradation in amplifying
and sharpening the transient Wnt signal. Lee and colleagues thus concluded that
Axin is the limiting factor in controlling the β-catenin degradation process. Another
key result of the model analysis regards the differential regulation of β-catenin levels
by the scaffolding proteins Axin and APC. APC binds its interaction partners in an
ordered manner, whereas Axin binds them randomly. The theoretical investigation
also indicated that Axin plays an essential role in preventing the accumulation of
β-catenin at decreased APC concentrations.
The Lee Model is to date the most cited quantitative model of the Wnt pathway
and widely used as a reference regarding further Wnt modelling. It also forms the
basis of my modelling approaches.
4.1.1. Including transcriptional feedback and crosstalk
The first extension of the Lee Model was done by Cho et al. [2006] (the “Cho
Model”), who added a negative feedback loop provided by β-catenin/TCF-induced
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synthesis of Axin2. The added reaction follows mass action kinetics. In their model,
Axin1 and Axin2 are combined into one species, i.e. “Axin”, since their function is
believed to be largely equivalent. The authors also combined the species β-catenin
and [β-catenin/TCF] of the Lee Model and termed them “available β-catenin”,
representing the pool of β-catenin available for nuclear translocation and transcrip-
tional activity. Please note that, although they refer to the nucleus, there are no
compartments included in their model. Furthermore, Cho et al. [2006] restricted
their analysis to the steady state behaviour of the system. Simulations of the Cho
Model evaluate the impact of various APC mutations on Wnt/β-catenin signalling,
as these are often observed to be the earliest initiating event for most colorectal
tumours. The mutations are modelled via variation of the corresponding parame-
ter values. Their results predicted that APC mutations are selected not based on
the maximal level of β-catenin but rather based on a distinct state of activity that
appears to be optimal for the tissue-specific tumourigenesis. They concluded that
the optimal level of β-catenin is determined by balancing β-catenin increase due
to pathway activation and its decrease due to induction of the negative feedback
through Axin2.
Similar to the Cho Model, Wawra et al. [2007] extended the Lee Model by in-
troducing negative feedback loops involving Axin or Dickkopf (Dkk1; inhibiting the
action of Dsh). These loops have previously been shown to induce oscillating ex-
pression patterns in many genes including Wnt pathway components, for example
during vertebrate somitogenesis. The additional reactions are modelled using de-
lay differential equations, allowing to consider time delays evoked by transcription,
translation and splicing. Gene expression is modelled based on cooperative activa-
tion and described by a sigmoidal Hill function. The intermediate products of the
transcriptional activity include Axin RNA (Ribonucleic acid) and Dkk1 RNA.
Perturbing the system up to 50% (single and multiple parameter perturbations as
well as initial condition variation), the authors performed an extended robustness
analysis of the Lee Model. Default parameter values were chosen according to the
Lee Model. They demonstrated the very robust behaviour of the pathway. By in-
troducing the feedback loop, the authors were able to induce oscillatory behaviour.
However, a remarkably increased β-catenin and Axin throughput and hence unreal-
istically high axin and β-catenin concentrations are necessary to reach an oscillation
threshold. Nevertheless, Wawra et al. [2007] showed that the Wnt/β-catenin path-
way is capable of generating oscillatory behaviour independent of external factors.
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Based on the Cho Model , Kim et al. [2007] investigated the crosstalk between the
Wnt and ERK (extracellular-signal-regulated kinase) pathways, which is known as a
major cellular proliferation signalling pathway and also involved in the pathogenesis
of various kinds of cancers. The crosstalk was found to create a positive feedback
loop. Kim et al. [2007] performed a qualitative comparison of model predictions to
experimental results obtained from HEK 293 (Human Embryonic Kidney) cells and
proposed that a positive feedback loop between the two pathways stimulates ERK
activity and hence increases the levels of β-catenin/TCF in a switch-like manner.
The model correctly predicts the consequences of Wnt/ERK crosstalk. However, it
incorporates parameters that remain yet to be experimentally validated.
4.1.2. Time scale analysis
Kru¨ger and Heinrich [2004] performed a systematic analysis of the Lee Model. Parts
of the analysis have already been published in Lee et al. [2003]. Their results have
been used to reduce the number of ODEs in the Lee Model from 15 to 7. The
authors also determined how the steady state concentrations of the involved proteins
changed when system parameters were varied. Their analysis revealed that (with
the exception of β-catenin/TCF) the steady state values of all variables were robust
to changes in the parameter values describing Wnt pathway activation.
A detailed asymptotic analysis was performed by Mirams et al. [2010] in order
to identify which pathway components are dominant on the different timescales
associated with Wnt signalling. Their analysis aimed at systematically simplifying
the model to understand how the components of the pathway interact. The authors
found that the pathway operates on three different timescales. By highlighting the
operation of different pathway components over different time scales associated with
the half-life of β-catenin, they derived a simplified model which was shown to retain
the essential behaviour of the full pathway. Thus, the original set of ODEs from the
Lee Model was reduced to a single ODE that represents the dynamics (accumulation
and degradation) of active β-catenin in response to a Wnt signal. The ODE takes
three reactions into account: synthesis of β-catenin, non-Axin dependent proteolysis
of β-catenin and Axin dependent degradation of β-catenin, where the (mediated)
influence of Wnt comes in. As the output of the pathway is usually the main object
of interest, the authors also regarded the β-catenin/TCF complex to complete the
model. This additional algebraic equation incorporates the equilibrium condition
derived from fast-binding kinetics for the reaction between TCF and β-catenin, as
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proposed by [Lee et al., 2003]. Taken together, the simplified model consisting of
β-catenin and [β-catenin/TCF] only contains seven parameters (expressed as groups
of original parameters) and still exhibits the same steady states and similar response
to a transient Wnt stimulus as the full model. Moreover, the asymptotic analysis has
been applied to the Cho Model. An additional production term was introduced to
model Axin2 feedback in response to β-catenin/TCF signalling. Again, the essential
behaviour of the model was retained.
4.1.3. Fold-change of β-catenin
A common feature of the models described above is that absolute levels of [β-
catenin/TCF] determine the pathway output. Goentoro and Kirschner [2009] in
contrast considered fold-changes in β-catenin pre and post pathway activation in
the Lee Model. On the basis of a dimensional analysis of the core model, the
reactions of the Lee Model were divided into three modules: input, degradation
and synthesis. In a detailed theoretical investigation, the authors showed that the
fold-change of β-catenin, which is defined as the ratio of the stimulated and the
unstimulated steady state concentration, were more robust to perturbations of sys-
tem parameters than changes in absolute levels of β-catenin. The generated data
suggests that Wnt-induced fold-changes in β-catenin are robust against small per-
turbations in the degradation module. In contrast, other signalling characteristics
(including the absolute values of β-catenin) are sensitive to perturbations in all mod-
ules. Therefore, the β-catenin fold-change was concluded to be the relevant readout
of the Wnt pathway, because in this way the system can compensate for natural
biological (both environmental and genetic) noise. Indeed, Goentoro and Kirschner
[2009] confirmed their results experimentally, as they perturbed components of the
pathway in mammalian cells by gene overexpression and pharmacological inhibitors
and thereby proved that fold-change of β-catenin is relevant for the phenotype.
4.2. The dual role of β-catenin
The model developed by van Leeuwen et al. [2007] (the “VanLeeuwen Model”) ad-
dresses the question of how the binding of β-catenin to E-cadherin alters its avail-
ability for gene expression due to Wnt signalling. The model thus incorporates
β-catenin’s dual – adhesive and transcriptional – function, as an increase in the
synthesis rate of E-cadherin enhances the cell-cell adhesion and may transiently de-
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crease the expression of target genes. The authors proposed two main hypotheses
concerning the balance between both functions: either β-catenin’s fate is determined
by competition between its binding partners, or Wnt induces folding of β-catenin
into a conformation allocated preferentially to transcription. The model consists
of 11 coupled ODEs, 6 of which describe different pools of β-catenin within the
three ‘compartments’, nucleus, cytoplasm and membrane. Still, following the Lee
Model, all kinetic reactions take place within a single cellular compartment. The
authors used the model to carry out a series of in silico experiments and compared
the behaviour of the systems governed by each hypothesis, as the experimental data
supporting each hypothesis were inconclusive. The model predicted that dynamic
measurements of E-cadherin levels following Wnt stimulation could be used to dis-
criminate between the two hypotheses. To date, this counter-intuitive predictions
remains to be tested. Furthermore, van Leeuwen et al. [2007] also exploited the
model to investigate the impact of the mutations most commonly observed in hu-
man colorectal cancer, where both target gene expression and cell-cell adhesion are
increased.
The VanLeeuwen Model was embedded in a multiscale approach combining sub-
cellular, cellular and tissue levels of organisation to investigate the dynamics of
intestinal tissue renewal. On the cellular level, the authors studied the contribution
of Wnt signalling to the interactions of neighbouring cells and to gene expression
and subsequent progression through the cell cycle [Van Leeuwen et al., 2009]. This
multiscale model was further analysed by Mirams et al. [2012] and Fletcher et al.
[2012]. The contents of their analyses are however beyond the scope of this work
and are therefore not described here. For an extensive review on multiscale Wnt
modelling, the reader is referred to [Lloyd-Lewis et al., 2013].
4.3. Receptor activation and inhibition
Kogan et al. [2012] developed a detailed mechanistic model (the “Kogan Model”)
focussing on the initial sequence of events in the Wnt pathway, from ligand binding
to β-catenin accumulation, and the effects of pathway inhibitors. The model cap-
tures the following processes: i) the pathway is activated by binding of Wnt ligands
to the Frizzled receptor; (ii) the resulting ligand-receptor complex may recruit an
unoccupied LRP receptor and create a ternary complex Wnt/Frz/LRP; and (iii) the
latter complex transduces the signal into the cell and interferes with the destruction
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cycle of β-catenin. The Kogan Model is based on the Lee Model. However, in order
to reduce the complexity of the intracellular part, the authors have assumed that
the destruction complex is also in equilibrium with all of its components, meaning
that its total concentration is conserved. Furthermore, β-catenin phosphorylation,
dissociation and degradation are modelled as a one-step process. Model parameters
were retrieved from experimental data reported previously. The experiments were
conducted with mouse fibroblasts (L cells), which do not express cadherin. Hence,
the cytoplasmic β-catenin is free and not bound to the membrane.
The predictive ability of this general model was validated using quantitative data
from independent experiments (also using L cells), testing the effects of Wnt3a and
sFRP (secreted Frizzled-related protein) on β-catenin accumulation. Additional
experiments measuring inhibition by Dkk1 also validated corresponding model pre-
dictions. Using simulations of the combined effects of sFRP and Dkk1, the authors
predicted synergism between the two inhibitors, which yet remains to be verified
experimentally.
4.4. The impact of stochastic variation
The first stochastic investigation of the core Wnt/β-catenin pathway was presented
by Mazemondet et al. [2012], who proposed a computational modelling approach
on cell cycle asynchrony and self-induced signalling in the context of the Wnt/β-
catenin pathway in ReNcell VM cells, which are derived from the ventral midbrain
of a ten week old fetus [Donato et al., 2007]. The model they developed is based on
the Lee Model and validated with wet-lab data obtained from Western blot exper-
iments [Mazemondet et al., 2011]. Their model extensions allow to switch between
stochastic and deterministic domains and also cover spatial aspects, i.e. the compart-
mental location of molecules. Using stochastic simulations, Mazemondet et al. [2012]
demonstrated that the impact of the cell cycle asynchrony on the average β-catenin
dynamics in cell populations is negligible. Furthermore, the authors showed that
low Axin amounts lead to significant stochastic effects that contradict experimental
observations and that are not observable in deterministic investigations.
4.5. Regulation of target gene expression
Benary et al. [2013] applied a mathematical modelling approach to investigate the
impact of different regulatory mechanisms of target gene expression with Wnt or
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APC concentration gradients. They developed a minimal model of Wnt/β-catenin
signalling and extended it to different regulatory mechanisms of target gene expres-
sion. The core signal transduction module of the model consists of five coupled
ODEs and two conservation equations following mass action kinetics. The destruc-
tion complex is not modelled explicitly, but indirectly, as β-catenin destruction is
influenced by Wnt through active Dsh. Kinetic parameter values are set in strong
accordance to the Lee Model. The model extensions are i) linear and cooperative
activation of mRNA production, described with linear or Hill kinetics; ii) repression
of mRNA production; iii) an incoherent feedforward loop (iFFL), as β-catenin/TCF
complexes are proposed to induce the expression of a repressor of the mRNA pro-
duction, which counteracts the simultaneous direct activation of mRNA expression;
and finally iv) transcriptional feedback via TCF. The authors investigated these
mechanisms in dependence of the Wnt or APC concentration. They claimed that a
combination of these mechanisms with Wnt or APC gradients is sufficient to gen-
erate spatially distinct target gene expression patterns as have been observed ex-
perimentally in liver. Benary et al. [2013] found that cooperative gene activation in
combination with a feedback can establish sharp boarders of target gene expression
in dependence of the Wnt or APC concentration, whereas the iFFL renders the gene
expression independent of Wnt and APC. Under mutant conditions, their analysis
revealed that the impact on gene expression is determined by the gene regulatory
mechanisms and the APC concentration in the cell.
4.6. Validation based on mammalian systems
The computational models for the Wnt signalling pathway have so far been largely
based on the Lee Model (in which the authors derived their quantitative data un-
derlying the model parametrisation from Xenopus egg extracts), due to the lack of
corresponding mammalian data for the concentrations of key Wnt pathway com-
ponents. Therefore, the interpretation of predictions for mammalian systems is
limited. In order to close this gap, Tan et al. [2012] reported initial estimates of the
concentrations of β-catenin, APC, Axin, GSK3β and E-cadherin in five mammalian
cell lines in the basal (non-stimulated) state. To this end, a confocal microscopy
technique was developed to measure the average cell volume for each of the cell
lines, allowing calculations of the concentrations of the key proteins within cells.
Their results demonstrated significant differences in the concentrations of the Wnt
signalling proteins between the Xenopus egg extracts and mammalian whole cell
35
4. Modelling the Wnt/β-catenin pathway
lysates, in particular with respect to the Axin concentration. Tan et al. [2012] re-
ported that in mammalian cells, the concentrations of Axin are considerably higher
and comparable to other protein concentrations of the pathway. Besides, the authors
observed that mammalian cells have higher β-catenin concentrations than measured
in Xenopus extracts, despite having higher Axin concentrations. The newly acquired
quantitative data was integrated in the complete Lee Model. Using computational
simulations, the authors concluded that there is a need for recalibration of the model
for mammalian cells. To date, the kinetic parameters of the Wnt pathway, such as
reaction rate constants or dissociation constants, have not been measured in mam-
malian systems.
4.7. Open questions
Over the last decade, mathematical models have been used to increase our under-
standing of the Wnt/β-catenin pathway. The models I have presented in this chapter
mainly focus on the biochemical level and thus on intracellular interactions. They
are largely based on a small set of experimental observations. Model simulations
and analyses led to important insights and generated testable and counter-intuitive
predictions. However, several aspects of the pathway have not yet been addressed
by modelling. An example for a process that is under extensive experimental inves-
tigation and has not yet been modelled is Wnt secretion. Moreover, the idealised
biochemical models which have been developed so far are able to provide insights
into the cellular dynamics, although they only consider the ‘core’ Wnt pathway.
This raises questions about the role of the large number (i.e. more than 200) of
potential Wnt regulators. Incorporating some of these additional regulating com-
ponents may allow for context-dependent cross-talk of Wnt/β-catenin signalling to
non-canonical [Katoh, 2005, Kohn and Moon, 2005] and non-Wnt pathways such as
Notch signalling [Lloyd-Lewis et al., 2013].
Another aspect that has not been addressed by modelling is the intercellular com-
partmentalisation. This issue has also been noticed and mentioned by Kofahl and
Wolf [2010]. With the exception of the stochastic model by Mazemondet et al. [2012],
all models discussed above treat the interior of the cell as a well-mixed environment.
In practice, however, cells comprise distinct regions with proteins migrating between
them: β-catenin and other key pathway regulators are present in the cytoplasm and
the nucleus, and bind to fixed cellular structures, such as the plasma membrane.
This raises questions about the subcellular distribution of concentrations and activ-
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ities in the compartments, and the shuttling between them [Kofahl and Wolf, 2010].
As described in Sections 2.2 and 2.4, not only β-catenin as a transcriptional cofactor
shuttles between cytoplasm and nucleus. Interestingly, a surprisingly high number
of cytoplasmic Wnt regulators, including the β-catenin antagonists APC, Axin and
GSK3, have also been localised in the nucleus.
One conceivable hypothesis, attempting to explain why these proteins translocate
into the nucleus, is that the antagonists mainly regulate the subcellular localisation
of β-catenin by retaining it in the cytoplasm, as well as in the nucleus [Krieghoff
et al., 2006]. Another possible hypothesis is that the destruction complex is as-
sembled and also active in the nucleus [Caspi et al., 2008]. In this case, nuclear
β-catenin could also be marked for degradation, allowing antagonist shuttling to
more efficiently inhibit Wnt signalling. Alternatively, however, the question arises
whether it is possible that, in certain scenarios, Wnt signalling benefits from antag-
onist shuttling.
To date, the functional relevance of antagonist shuttling in the Wnt/β-catenin path-
way remains to be determined. This open question is the challenge that inspires
the research presented in this thesis. Using mathematical modelling and model
analysis, I study the following key questions: Does the nucleo-cytoplasmic shutt-
ling of β-catenin antagonists APC, Axin and GSK3 influence the [β-catenin/TCF]
concentration, which is considered as the output of Wnt signalling? Can the [β-
catenin/TCF] concentration be maximised by antagonist shuttling, leading to an
optimised signal transduction through the cell? How is the output of the pathway
influenced by cytoplasmic and nuclear retention of β-catenin, and by phosphoryla-
tion and subsequent degradation of β-catenin?
In order to answer these questions, I develop novel compartmental models and anal-
yse them with respect to nucleo-cytoplasmic shuttling of β-catenin and its antag-
onists. They are currently the only deterministic models of the Wnt/β-catenin
pathway on a subcellular, compartmental scale and have been noticed as such in
the research community (see [Lloyd-Lewis et al., 2013, Figure 2]). These models
account for the compartmental structure of the cell and allow for the retention of
β-catenin by APC and the degradation of β-catenin by the destruction complex in
the cytoplasm as well as in the nucleus.
The compartmental models and their analyses are presented in the following Chap-
ters 5 and 6.
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In this chapter I investigate the impact of nucleo-cytoplasmic shuttling of one of the
key β-catenin antagonists – namely APC – on the [β-catenin/TCF] concentration.
To this end, I establish and analyse a mathematical model using the compartmen-
talised ODE formalism (see Sections 3.2 and 3.3). It is the first deterministic model
of the Wnt/β-catenin pathway on a subcellular, compartmental scale [Lloyd-Lewis
et al., 2013]. It consists of two compartments, cytoplasm and nucleus, and allows
for protein complex formation in each compartment as well as β-catenin and APC
shuttling between nucleus and cytoplasm. As in this novel model the β-catenin
concentration is mainly regulated through compartmental retention by APC, I refer
to it as the “Retention Model”. For the model analysis, I focus on the in-
fluence of nucleo-cytoplasmic shuttling of APC on the steady state concentration
of [β-catenin/TCF] and hence neglect β-catenin degradation as well as membrane
associated events. The key questions I address in this chapter are: Does the nucleo-
cytoplasmic shuttling of APC influence the [β-catenin/TCF] concentration, which is
considered as the output of Wnt signalling? Can the [β-catenin/TCF] concentration
be maximised by APC shuttling? How is the output of the pathway influenced by
cytoplasmic and nuclear retention of β-catenin?
The experimental results summarised in Chapter 2 provide the structural basis of the
Retention model. The main protagonist β-catenin and its antagonist APC shuttle
independent of each other between the two compartments; the complexes are, how-
ever, unable to cross the nuclear envelope [Krieghoff et al., 2006]. The construction
of the Retention Model is presented in Section 5.1. Next, I investigate the influence
of nucleo-cytoplasmic shuttling of APC on the output of the Wnt signalling. For this
reason I systematically examine the influence of different shuttling mechanisms: In
a first step, I neglect the nucleo-cytoplasmic shuttling of APC. I then study diffusive
nucleo-cytoplasmic shuttling of APC and analyse the influence of cytoplasmic and
nuclear retention of β-catenin by APC. Finally, I choose facilitated nuclear export
of APC, which is based on a Michaelis-Menten type rate law. In Section 5.2, the
results and the discussion of the model analysis are presented. A conclusion is given
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State variable Original variable Interpretation
X1 β-catc free cytoplasmic β-catenin
X2 APCc free cytoplasmic APC
X3 β-catn free nuclear β-catenin
X4 APCn free nuclear APC
X5 [β-cat/APC]c cytoplasmic retention complex [β-cat/APC]
X6 [β-cat/APC]n nuclear retention complex [β-cat/APC]
X7 TCF free nuclear transcription molecules
X8 [β-cat/TCF] transcription complex [β-cat/TCF]
Table 5.1.: Definition of the eight state variables of the system. Squared brackets
denote protein complexes. The indices n and c denote nuclear and cytoplasmic protein
concentrations, respectively. In the text, variables in steady state are annotated by an
asterisk, i.e. ∗.
in Section 5.3. The contents of this chapter is adapted from [Schmitz et al., 2011]
and reproduced with permission from Elsevier.
5.1. Construction of the Retention Model
The Retention model is a simple biochemical reaction network model consisting of
two compartments, cytoplasm and nucleus. The model describes nucleo-cytoplasmic
shuttling of β-catenin (β-cat), the main protagonist of the canonical Wnt signalling
pathway, and its antagonists APC. It is depicted in Figure 5.1. This model struc-
ture is based on experimental findings (see Chapter 2 for details): Both key players
are able to shuttle between the nucleus and the cytoplasm (ν1 and ν2, respectively)
[Neufeld et al., 2000, Rosin-Arbesfeld et al., 2003, Wiechens and Fagotto, 2001]. Fur-
thermore, they can associate to and dissociate from a common complex [β-cat/APC]
within the cytoplasm (ν3) as well as within the nucleus (ν4) [Krieghoff et al., 2006].
These complexes, however, are not able to cross the nuclear envelope [Eleftheriou
et al., 2001, Krieghoff et al., 2006, Wiechens and Fagotto, 2001].
Additionally, nuclear β-catenin can interact with TCF (ν5) to activate transcription
[Cong and Varmus, 2004]. Hence, the complex [β-cat/TCF] is considered as the
output of both, the Wnt pathway [Lee et al., 2003] and the Retention model.
The reaction network is translated into a system of ODEs describing temporal
changes of protein concentrations as functions of interactions and transport pro-
cesses (see Section 3.3 for details). Each protein and protein complex concentration
is represented by a variable in the mathematical model (see Table 5.1). Taking the
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Figure 5.1.: Biochemical reaction network of the Retention Model describing nucleo-
cytoplasmic shuttling of β-catenin and APC, and protein complex formation of β-
catenin with APC and TCF, respectively. The reactions are numbered 1 to 5. In
Table 5.1 the protein names are translated into state variables (X1 to X8).
five interactions into account, the dynamics of the biological system are determined
by the following eight coupled ODEs:
X˙1 = −ν1 − ν3
X˙2 = −ν2 − ν3
X˙3 = +ν1 − ν4 − ν5
X˙4 = +ν2 − ν4 (5.1)
X˙5 = +ν3
X˙6 = +ν4
X˙7 = −ν5
X˙8 = +ν5
where the reaction rates vi on the right-hand side are functions of the protein or
protein complex concentrations, each one of them describing biochemical reactions
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or transport processes:
ν1 = F1(X1, X3)
ν2 = F2(X2, X4)
ν3 = k3X1X2 − k−3X5 (5.2)
ν4 = k4X3X4 − k−4X6
ν5 = k5X3X7 − k−5X8.
Binding and dissociation processes (ν3, ν4 and ν5) are described with mass-action
kinetics, see Equation (3.3). The functions F1(X1, X3) and F2(X2, X4) account
for nucleo-cytoplasmic transport processes of β-catenin and APC, respectively. To
investigate the influence of the nucleo-cytoplasmic shuttling on the output of the
system, I consider different translocation mechanisms which are presented in the
Section 5.2.
5.1.1. Rapid equilibrium approximations and conservation
equations
Independent of the translocation mechanism, one can apply the following approxi-
mations and conservation equations in order to simplify the model: I assume that
the binding and dissociation processes considered in the network (i.e. β-catenin to
APC and β-catenin to TCF) will approach the quasi-equilibrium rapidly, leading to:
K3 =
X1X2
X5
=
k−3
k3
(5.3)
K4 =
X3X4
X6
=
k−4
k4
(5.4)
K5 =
X3X7
X8
=
k−5
k5
. (5.5)
The biochemical reaction network (see Figure 5.1) implies the existence of three
conservation equations. This means that total amounts of molecules are conserved.
In this case, the conserved quantities correspond to the total number of molecules
of β-catenin, APC, and TCF. If more than one compartment is considered, con-
servation sums can only be applied to molecule numbers, not to concentrations.
To calculate the corresponding protein concentrations, the compartmental volumes
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must be taken into account. For the sake of simplicity, I assume that the volumes
and capacities of nucleus and cytoplasm are of the same size. This assumption leads
to the following expressions exhibiting the double total concentrations B, A and T ,
respectively:
total β-catenin: 2B = X1 +X3 +X5 +X6 +X8 (5.6)
total APC: 2A = X2 +X4 +X5 +X6 (5.7)
total TCF: 2T = X7 +X8. (5.8)
The set of differential equations can be simplified by considering the conservation
equations and the rapid equilibrium approximations to the binding reactions. This
results in a subdivision of dependent variables. The dependent variables are alge-
braic functions of other variables, which are determined as solutions of the remaining
equations.
Elimination of X7 and X8:
These dependent variables can be expressed as a function of the variable X3 using
the conservation condition for TCF (Equation (5.8)) and the equilibrium condition
for β-catenin to TCF binding (Equation (5.5)). The combination of both yields
X7 =
2K5T
K5 +X3
and X8 =
2TX3
K5 +X3
. (5.9)
Elimination of X5 and X6:
Both dependent variables are eliminated by the equilibrium conditions for the bind-
ing of β-catenin to APC in the cytoplasm and nucleus, respectively (Equations (5.3)
and (5.4)).
X5 =
X1X2
K3
and X6 =
X3X4
K4
. (5.10)
5.1.2. Differential equations for the remaining variables
Substituting the dependent variables of Equations (5.9) and (5.10), into the ODE
system (5.1), the dynamics of the remaining variables are determined by the nucleo-
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cytoplasmic reaction rates:
X˙1 = −F1(X1, X3) = −X˙3
X˙2 = −F2(X2, X4) = −X˙4. (5.11)
The connection between the variables is given by the conservation relations of β-
catenin and APC, described by Equations (5.6) and (5.7), where the dependent
variables of Equations (5.9) and (5.10) have been substituted:
total β-catenin:
2B = X1 +X3 +
X1X2
K3
+
X3X4
K4
+
2TX3
K5 +X3
(5.12)
total APC:
2A = X2 +X4 +
X1X2
K3
+
X3X4
K4
(5.13)
Equations (5.11) – (5.13) depend on four variables (X1, ..., X4) and can thus be
solved in steady state for different nucleo-cytoplasmic transport mechanisms. The
other four dependent variables can afterwards be calculated with Equations (5.9)
and (5.10).
5.1.3. How to determine the steady state solution
The network depicted in Figure 5.1 includes neither a time dependent input nor
output. I investigate a closed system without a stimulus, transcription or degrada-
tion, therefore all transport processes are in steady state. To determine the steady
states, i.e. the stationary solutions of the model, I calculate the states in which
the time derivatives vanish (see Section 3.4.1). The steady state concentrations are
annotated by an asterisk. Considering the conservation equations and substituting
X∗1 and X
∗
2 (Equations (5.11)) yields two algebraic equations that depend on X
∗
3
and X∗4 . Independent of the chosen transport mechanism, substitution always leads
to an algebraic equation in which X∗3 (i.e. nuclear β-catenin) is the only remaining
variable. It has the form of a polynomial with respect to X∗3 , and depends on dis-
sociation and shuttling constants and total protein concentrations. The solution of
the polynomial can be determined in general terms using computer algebra based on
symbolic maths (e.g. MAPLE or MATLAB). However, the particular expressions
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are far too complex to tell us much about the system’s behaviour. The stationary
solution has hence determined numerically using the “roots” (for cubic polynomi-
als) or “fzero” (for polynomials of higher order) function in MATLAB. The root
finding algorithm used in the “fzero” function depends on the initial value of search.
Therefore one has to make sure to find every biological sensible basin of attraction.
I investigated parameter space by generating randomised parameter values for those
parameters describing nucleo-cytoplasmic shuttling. In the following I consider and
analyse different transport mechanisms.
5.2. Results and discussion
In this section, I use the model, which was developed in the previous section, to
investigate the impact of nucleo-cytoplasmic shuttling of APC and compartmental
retention of β-catenin by APC on the [β-catenin/TCF] concentration.
The protein β-catenin not only exhibits the intrinsic ability to enter the nucleus, but
also to move bidirectionally across the nuclear envelope, proposing a free, nondirec-
tional nuclear translocation model for β-catenin [Wiechens and Fagotto, 2001, Xu
and Massague´, 2004]. I will therefore consider pure diffusion for nuclear transloca-
tion of β-catenin.
The nucleo-cytoplasmic shuttling of APC, however, depends on indirect interac-
tion with the NPCs and occurs in both directions by facilitated transport [Neufeld
et al., 2000, Rosin-Arbesfeld et al., 2000]. In my approach, the influence of nucleo-
cytoplasmic shuttling of APC on the output of the Wnt signalling is investigated by
studying different shuttling mechanisms:
In a first step, I neglect the nucleo-cytoplasmic shuttling of APC, which means that
APC is only located in the cytoplasm. This system serves as a reference system in
order to examine the influence of APC shuttling. I then study nucleo-cytoplasmic
shuttling of APC and its effect on the output of the pathway. For the sake of
simplicity, I first assume diffusion of APC across the nuclear envelope as proposed
for nucleo-cytoplasmic shuttling of β-catenin. I start by setting all dissociation
constants and total concentrations according to measurements and estimations con-
ducted by the Kirschner group in the Wnt off-state in Xenopus oocytes extracts to
[Lee et al., 2003], see Table 5.2. These numbers serve as the default parametrisa-
tion and hence form the starting point for the investigation of the effect of nucleo-
cytoplasmic antagonist shuttling. Next, I analyse the influence of cytoplasmic and
nuclear retention of β-catenin by APC, by varying the respective dissociation con-
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stants. Then, I choose a more complicated but more realistic approach for a APC’s
shuttling mechanism and assume facilitated nuclear export, which is based on a
Michaelis-Menten type rate law.
5.2.1. Absence of APC shuttling
Absence of APC shuttling is described by setting the antagonist shuttling constants
to zero (see Equations (5.14)). This system serves as a control for investigating the
influence of antagonist shuttling on X∗8 = [β-cat/TCF]. In this case, the antagonist
APC resides in the cytoplasm and is not able to cross the nuclear envelope.
F1(X1, X3) = k1X1 − k−1X3
F2(X2, X4) = 0 (5.14)
X4 = X6 = 0
Hence, the system depicted in Figure 5.1 simplifies significantly. The system reduces
from eight to six variables. In steady state we find:
X∗1 =
k−1
k1
X∗3 = K1X
∗
3
X∗2 =
2K3A
K3 +X∗1
(5.15)
X∗5 =
2AX∗1
K3 +X∗1
.
Substituting these solutions into Equation (5.12), the steady state solutions is ob-
tained as the roots of a cubic polynomial with respect to X∗3 :
X∗33

(K1 + 1)K1

+X∗23

2K1(A−B + T ) + (K1 + 1)(K3 +K1K5)

(5.16)
+X∗3

2K1K5(A−B) + 2K3(T −B) +K3K5(K1 + 1)

− 2BK3K5 = 0.
Therefore, the steady state concentration ofX∗8 is also only, but explicitly, dependent
on the dissociation and shuttling constants as well as the conserved total protein
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Parameter name Default value Description
K3 1200 nM binding of β-catenin to APC (cytoplasm)
K4 1200 nM binding of β-catenin to APC (nucleus)
K5 30 nM binding of β-catenin to TCF (nucleus)
A 100 nM Total concentration of APC
B 35 nM Total concentration of β-catenin
T 15 nM Total concentration of TCF
Table 5.2.: The default parametrisation following Lee et al. [2003]. Numeric values
and description of the parameters of the model in its default state. The Ki-parameters
are dissociation constants Ki = k−i/ki, the others (A,B, T ) illustrate total protein
concentrations. These parameters are crucial for simplifying the system using rapid
equilibrium approximations and conservation equations.
concentrations.
A cubic polynomial has one to three solutions. We find that there exist three
solutions, which raises the question of their ranges and stability. If two biological
meaningful and stable steady states coexist, the system exhibits bistability. Hence
hysteresis-like behaviour can be expected when crossing bifurcation points. How-
ever, in every parametrisation two of the three steady states solutions exhibit at
least one negative protein concentration. I investigated parameter space by gen-
erating parameter values for the shuttling parameters, i.e. K1 ∈ [10−4, 104]. In a
biological sensible range, the system remains monostable. This is therefore a numer-
ically obtained finding, which originates from the strict condition that all variable
and parameter values must be positive in order to be biologically meaningful.
The steady state analysis of the ODE model leads to the dependency of the steady
state concentration [β-cat/TCF]∗ on the ratio of rate constants for nucleo-cytoplasmic
shuttling of β-catenin (K1 =
k−1
k1
), which depicted in Figure 5.2. The parameter K1
is defined as the ratio of the shuttling rate constants of β-catenin, which is equal to
the ratio of free protein concentrations in the cytoplasm and nucleus calculated in
steady state (Equations (5.15), top line). The smaller the value of K1, the higher
the concentration of free β-catenin in the nucleus. If more β-catenin is located
in the nucleus, the output of the pathway is maximised in both presented cases.
This meets our expectations, as only nuclear β-catenin is able to interact with TCF
and therewith initiate target gene expression. However, a certain plateau of [β-
cat/TCF]∗ ∼ 19 nM cannot be exceeded. This is due to the fact that the binding
of β-catenin to TCF is limited by the value of its dissociation constant K5. This
constant regulates the level of the plateau height: decreasing K5 increases the height
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Figure 5.2.: The reference model without APC shuttling. The steady state concentration
[β-cat/TCF]∗ is depicted in dependence on the ratio of shuttling rate constants of β-
catenin (K1). The blue curve is obtained using the default parametrisation (Table 5.2);
for the green curve, K3 = K5 = 30 nM are chosen to account for increased cytoplasmic
retention.
of the plateau.
In Figure 5.2, the blue curve is obtained using the default parametrisation (Table
5.2). The green curve in comparison is obtained if K3 is reduced to 30 nM. This
lower value corresponds to a higher affinity of cytoplasmic β-catenin to bind APC
and therefore describes a higher cytoplasmic retention of β-catenin by APC. In this
parametrisation, β-catenin’s binding to TCF and to APC occurs equally likely. The
variation in values for K3 does not influence the height of the minimal or maximal
plateau but shifts the curve to smaller values of K1. For K1 = 1, the steady state
concentration [β-cat/TCF]∗ is decreased by half, because of the increased competi-
tion of the antagonist with the transcriptional factor for binding to β-catenin. The
results therefore show that cytoplasmic retention of β-catenin by its antagonist APC
influences the output of the model without antagonist shuttling.
5.2.2. Diffusive nucleo-cytoplasmic shuttling of APC
In the following, I investigate the effects of nucleo-cytoplasmic antagonist shuttling
on the steady state concentration [β-cat/TCF]∗. First, I assume diffusive shuttling
for β-catenin and APC. All translocation processes across the nuclear envelope are
modelled as simple as possible, meaning that transport is based on diffusion. Thus,
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nucleo-cytoplasmic shuttling is described by linear rate equations:
F1(X1, X3) = k1X1 − k−1X3
F2(X2, X4) = k2X2 − k−2X4 (5.17)
The index of the shuttling constants (k1, k−1, k2, k−2) is positive for transport into
the nucleus and negative for the transport back to the cytoplasm. In steady state
the following relations are obtained:
X∗1 =
k−1
k1
X∗3 = K1X
∗
3
X∗2 =
k−2
k2
X∗4 = K2X
∗
4 (5.18)
By considering the conservation equations (5.12) and (5.13) and substituting X∗1
and X∗2 as presented in Equations (5.18), two algebraic equations are obtained,
which depend on X∗3 and X
∗
4 . Solving Equation (5.13) for X
∗
4 and substituting into
Equation (5.12) leads to the following equation in which X∗3 (i.e. nuclear β-catenin)
is the only remaining variable. It also has the form of a cubic polynomial with
respect to X∗3 :
X∗33

(k1 + 1)C1

+X∗23

2C1(A−B + T ) + C2 + (K1 + 1)K5C1

(5.19)
+X∗3

2K5C1(A−B) + 2(T −B)(K2 + 1) + C2K5

− 2K5B(K2 + 1) = 0.
where
C1 =
K1K2
K3
+
1
K4

(5.20)
and
C2 = (K1 + 1)(K2 + 1). (5.21)
I investigated parameter space by generating parameter values for the shuttling
parameters, i.e. K1,2 ∈ [10−4, 104]. As discussed in the previous case without APC
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shuttling, again only one positive, and therefore biological meaningful solution exists.
The standard (default) parameterisation
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Figure 5.3.: Influence of diffusive nucleo-cytoplasmic shuttling of APC on [β-cat/TCF]∗.
The steady state concentration [β-cat/TCF]∗ is depicted in dependence on the ratio of
shuttling rate constants of β-catenin (K1) and APC (K2). a) The default parametrisa-
tion: The black curve is equal to the blue curve in Figure 5.2. For this parametrisation,
the steady state analysis indicates that the shuttling rate constant ratio of β-catenin
has a much higher impact on [β-cat/TCF]∗ than the ratio of shuttling rate constants of
APC. b) K3 = 30 nM. The black curve is equal to the green curve in Figure 5.2: The
steady state concentration of [β-cat/TCF]∗ crucially depends not only on β-catenin, but
also on APC shuttling. c) K4 = 30 nM: The black curve is equal to the green curve in
Figure 5.2. The steady state concentration [β-cat/TCF]∗ only decreases in comparison
to the reference curve. d) K3 = K4 = 30 nM: For K1 < 1 the effect of nuclear retention
is dominant, for K1 > 1 cytoplasmic retention is mainly determining the steady state
concentration of [β-cat/TCF]∗.
First, all dissociation constants and total protein concentrations are set to their
50
5.2. Results and discussion
default values (see Table 5.2). As a result of the steady state analysis, it is obtained
that [β-cat/TCF]∗ depends on the biochemical binding and shuttling parameters.
The steady state concentration [β-cat/TCF]∗ as a function of the nucleo-cytoplasmic
shuttling rate constant ratios (K1 and K2) is presented in Figure 5.3a. In this
parametrisation, the shuttling ratio of β-catenin (K1) has a much higher impact
on the output than the shuttling ratio of APC (K2). The shape of the curve is
qualitatively very similar to the result obtained with the reference model presented
in Figure 5.2. For this model, it is also more favorable for the output of the path-
way, if more β-catenin is located in the nucleus. The plateau has the same height
as the plateau of the reference model. APC shuttling parameter values between
K2 = 0.01 and K2 = 100 exhibit an almost identical output, even if the param-
eter values of K2 are further increased or decreased (data not shown). Thus, for
the default parametrisation, the steady state concentration [β-cat/TCF]∗ is only
slightly influenced by APC shuttling. This is due to the large dissociation constants
describing the binding of APC to β-catenin, i.e. K3 = K4 = 1200 nM (see Table
5.2), which exceeds the dissociation constant of TCF to β-catenin by a factor of 40.
Hence, β-catenin has a much higher affinity to bind to TCF than to APC and the
concentration of the complex [β-cat/APC]∗ can neither reach high numbers in the
cytoplasm nor in the nucleus. Subsequently, β-catenin can neither be retained in
the nucleus nor cytoplasm by its antagonist APC. Thus, the influence of antagonist
shuttling is negligible.
In the next section, I study the question whether lower dissociation constants can
account for a greater impact of APC shuttling on the steady state concentration
[β-cat/TCF]∗ in comparison to the values of the reference model.
The impact of the dissociation constants
For the default parametrisation, the affinity of β-catenin to bind to APC is low:
K3,4 = 1200 nM (experimentally based estimation by the Kirschner group [Lee et al.,
2003]). However, it has been demonstrated that phosphorylation enhances the abil-
ity of APC to interact with β-catenin in vitro [Rubinfeld et al., 1996]. Moreover,
Sierra et al. [2006] concluded from their experiments that β-catenin cannot bind un-
phosphorylated APC efficiently and that CK1 phosphorylation of APC might induce
high-affinity binding to β-catenin and even trigger its dissociation from LEF/TCF.
Seo and Jho [2007] proposed that accumulation of cytoplasmic β-catenin induces
phosphorylation of APC and that phosphorylated APC retains β-catenin. In accor-
dance with these findings, I investigate the influence of small values for dissociation
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constants (K3,4 = 30 nM) between β-catenin and APC. Lower dissociation constants
correspond to a higher binding affinity and hence higher possible compartmental re-
tention. I choose these specific values to account for a “fair” competition between
TCF and APC for β-catenin binding. It is still selected arbitrarily. However, the
results do not change qualitatively if other values (10 to 120 nM) were chosen. Since
APC phosphorylation can occur in both compartments, nucleus and cytoplasm, the
two different parameter values are changed independently: first, I decrease K3 to
describe an enhanced cytoplasmic retention and second, I decrease K4 to account for
an enhanced nuclear retention of β-catenin by APC. Different dissociation constants
in nucleus and cytoplasm can be due to e.g. different biochemical compositions of
the two compartments. In a last step I show the combined effect of nuclear and
cytoplasmic retention of β-catenin by APC.
For K3 = 30 nM, the binding affinity of β-catenin to APC in the cytoplasm is
equal to the binding affinity of β-catenin to TCF in the nucleus (K5 = 30 nM).
The steady state analysis leads to the dependency of [β-cat/TCF]∗ on the nucleo-
cytoplasmic shuttling rate constant ratios presented in Figure 5.3b. The dependency
on the shuttling ratio of β-catenin (K1) is plotted for different parameter values of
K2, which captures the shuttling ratio of APC. The shape of all curves is similar to
the ones obtained with the default parametrisation. In contrast to the default case
presented in Figure 5.3a however, the curves for different K2 are visibly shifted by
different extent along the x-axis. This leads to a qualitatively different dependency
of the output of the model on the shuttling of APC. The curves are shifted such
that they intersect in one specific point K ′1 ≈ 3 · 10−2. For K1 values smaller
than K ′1, the steady state concentration of [β-cat/TCF]
∗ is higher, if the shuttling
constant of APC is larger, but it cannot exceed the concentration obtained with
the reference model. For small values of K1, most of the β-catenin proteins are
located in the nucleus. In this case, a higher concentration of [β-cat/TCF]∗ is
obtained, if APC remains in the cytoplasm, because cytoplasmic APC and nuclear
TCF cannot compete directly for β-catenin binding. However, for K1 > K
′
1 we see
that the concentration of [β-cat/TCF]∗ is larger than the reference concentration
of [β-cat/TCF]∗ (Figure 5.3b). Thus, nucleo-cytoplasmic shuttling of APC can
increase the output of Wnt signalling in comparison to the reference model. This
result can be explained as follows (see Figure 5.4): If APC is highly concentrated
in the nucleus (K2 is small, green curves), and at the same time the dissociation
constant of nuclear APC to β-catenin (K4 = 1200 nM) is large, only a small amount
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Figure 5.4.: Influence of diffusive shuttling of the protein and complex concentration of
β-catenin and APC in the cytoplasm (top row) and nucleus (bottom row) for K3 = 30
nM. The steady state concentrations are plotted in dependence on the ratios of the
shuttling rate constants of β-catenin (K1) and its antagonist APC (K2), respectively.
of β-catenin can bind to APC (see Figure 5.4f). Thus, most of the APC proteins
remain free and unbound in the nucleus (Figure 5.4e). This in turn means that the
high binding affinity of cytoplasmic APC and β-catenin cannot be fully utilized due
to a low cytoplasmic APC concentration (Figure 5.4b), hence the concentration of
[β-cat/APC] in the cytoplasm is small (Figure 5.4c). As a result, more β-catenin
remains unbound to APC (Figure 5.4a and 5.4d) and can hence bind to TCF (Figure
5.3b). Cytoplasmic retention of β-catenin is down-regulated due to APC nucleo-
cytoplasmic shuttling. Therefore, in this parametrisation Wnt signalling benefits
from antagonist shuttling.
In order to investigate the impact of nuclear retention, I now increase the affinity of
β-catenin to APC in the nucleus, such that it is equal to the affinity of β-catenin
to bind to TCF in the nucleus (K4 = K5 = 30 nM). The results of the steady state
analysis based on these parameter values are shown in Figure 5.3c. The steady state
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concentration of [β-cat/TCF]∗ is plotted with respect to changes in the parameter
values K1 and K2. The black curve where K2 = 100 also equals the reference case
(Figure 5.2). The curves show that the output of the diffusive shuttling model can
only be reduced with these parameter values, in contrast to the results presented in
Figure 5.3b. This is due to an enhanced competition of APC and TCF for β-catenin
binding in the nucleus.
Next, I choose all three dissociation constants to have the same value (K3 = K4 =
K5 = 30 nM). The steady state concentration [β-cat/TCF]
∗ is shown in Figure 5.3d.
We see a combination of the above discussed effects. For K1 < 1 the effect of nuclear
retention is dominant, as more β-catenin is located in the nucleus: Higher nuclear
concentration of APC hence corresponds to higher competition of nuclear APC and
TCF for β-catenin binding and therefore reduces the output. For K1 > 1, the effect
of cytoplasmic retention is prevalent; Cytoplasmic retention is down-regulated due
to nuclear import of APC. Interestingly, the [β-cat/TCF]∗ concentration benefits
from a decreased competition of cytoplasmic APC and TCF for β-catenin binding,
although the binding affinity of β-catenin to APC in the nucleus is equally high.
This means that [β-cat/TCF] signalling can even benefit from APC shuttling if β-
catenin is retained by APC also in the nucleus. The intersection point in Figure
5.3d corresponds to the situation in which nuclear and cytoplasmic retention are
equally powerful.
To sum up, diffusive nucleo-cytoplasmic shuttling of APC has a significant influence
on the steady state concentration of [β-cat/TCF]∗. My results demonstrate that the
shuttling of the antagonist can yield an enhanced output of the system. I showed that
this enhancement can be induced by a high binding affinity of APC and β-catenin
in the cytoplasm, which can be caused by phosphorylation of APC [Rubinfeld et al.,
1996]. Phosphorylation of APC can be induced by a high cytoplasmic β-catenin
concentration [Seo and Jho, 2007]. The latter is supported by a high APC shuttling
ratio leading to an accumulation of free APC in the nucleus. However, this effect
is also visible if the nuclear [β-cat/APC] concentration is high due to enhanced
binding affinity between the two proteins in the nucleus. Therefore the question
arises, if [β-cat/TCF]∗ can further be maximised by saturated nuclear export and
low binding affinity of β-catenin and APC in the nucleus, which is studied in the
following section.
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5.2.3. Facilitated export of APC
In contrast to the previous cases, the process of the nuclear export of APC across the
NPC is now considered as facilitated transport [Xu and Massague´, 2004]. It is rea-
sonable to assume that the concentration of APC is in excess of the NPC. Therefore,
the Michaelis-Menten approach based on the quasi-steady state assumption can be
applied [Millat et al., 2007] (see Section 3.3). Facilitated export of APC is modelled
by a Michaelis-Menten type function (see Equations (3.4)). APC exhibits a NES
[Neufeld et al., 2000, Rosin-Arbesfeld et al., 2000], and its export therefore depends
on the CRM1 exportin pathway. It is the formation of the transportin-protein com-
plex that restricts export rates and can lead to saturation [Timney et al., 2006].
This holds also true for the nuclear import of APC. However, we have seen in the
previous section that especially nuclear accumulation of APC yields a maximisation
of the output of the system. Therefore, and for the sake of simplicity, I restrict my
analysis to the saturation of nuclear export. The nuclear import of APC remains
diffusive.
F1(X1, X3) = k1X1 − k−1X3
F2(X2, X4) = k2X2 − vmaxX4
km +X4
(5.22)
In case of facilitated export of APC, the search of the steady states leads to the
following dependencies:
X∗1 =
k−1
k1
X∗3 = K1X
∗
3
X∗2 =
vmax X
∗
4
k2(km +X∗4 )
(5.23)
Substituting X∗1 and X
∗
2 in Equations (5.12) and (5.13), we obtain two algebraic
equations, which depend on X∗3 and X
∗
4 . Considering Equation (5.13) with its
substitutes, we see the following equation in which X∗3 (i.e. nuclear β-catenin) is
still depending on X∗4 :
X∗3 =
2Ak2km + C3X
∗
4 − k2X∗24
X∗4 (C4 +
k2
K4
X∗4 )
(5.24)
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where
C3 = 2Ak2 − k2km − vmax (5.25)
and
C4 = K1vmax +
k2km
K4
. (5.26)
Substituting these equations into the conservation equation (5.12), we end up with
a polynomial of 6th order with respect to X∗4 , which I omit to write down. However,
we may obtain up to six different roots and therefore steady state solutions. I
investigated parameter space by generating randomized parameter values for the
shuttling parameters, i.e. k2, vmax ∈ [10−3, 103] and km ∈ [10−8, 108]. Again, for this
parameter space only one biological sensible and meaningful solution exists.
For steady state analysis, I set K3 = K5 = 30 nM, K4 = 1200 nM and K1 = 1, as
chosen in the previous sections. In case of facilitated export, two extreme cases can
be considered: First, for km >> X4, the nuclear export of APC changes linearly with
the concentration of nuclear APC (X4), which corresponds to diffusive shuttling. In
this case, one obtains
Klin =
vmax
kmk2
= K2 (5.27)
in steady state. Second, for km << X4, the nuclear export is independent of X4;
it is therefore saturated. The nucleo-cytoplasmic shuttling of APC is in this case
determined by
Ksat =
vmax
k2
. (5.28)
Note that Ksat is independent of km. In Figure 5.5, the dependency of [β-cat/TCF]
∗
on the parameters describing the shuttling of APC is shown.
In the linear extreme case km >> X4, the results depending on Klin are equal to
the results obtained assuming diffusive APC export (see left border of the scatter-
plot presented in Figure 5.5, left panel), which meets our expectations (see Equa-
tion (5.27)). For decreasing km, more solutions are obtained on the high plateau,
but the height of this plateau does not exceed the results we obtain with the dif-
fusive model. For small half-saturation constants (km < 1 nM), the concentration
of [β-cat/TCF]∗ is completely determined by Ksat (see Figure 5.5, right panel), as
expected from Equation (5.28). In this case, export is saturated, hence more free
APC is located in the nucleus and the corresponding steady state solution is located
on the high plateau, which is in agreement with the results obtained for the diffusive
model. However, the maximum value of [β-cat/TCF]∗ ≈ 14 nM cannot be exceeded
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Figure 5.5.: Influence of facilitated nuclear export of APC on [β-cat/TCF]∗, K3 =
30 nM and K1 = 1: The steady state concentration [β-cat/TCF]
∗ is presented in
dependence on the ratios of the shuttling rate constant of APC Klin = vmax/k2km
(left panel) and Ksat = vm/k2 (nM) and km (right panel), respectively. Shuttling
parameters are generated randomly. Every dot corresponds to the solution for a specific
parametrisation.
due to saturated export. I therefore conclude that the concentration of [β-cat/TCF]∗
cannot be further maximised in response to facilitated and hence saturated export
of APC.
I also considered facilitated import. This results in a more complicated system which
is numerically more challenging, but did not yield any new insights.
The presented results thus show that it is possible to simulate the effects of saturation
by using pure diffusion, if the shuttling rate constant ratio is chosen appropriately.
A difference in the shuttling rate constants of significant orders of magnitude leads
to an accumulation of the protein in the respective compartment, which corresponds
to saturation in translocation.
5.3. Conclusions
Using compartmental modelling, I investigated the impact of nucleo-cytoplasmic
shuttling of APC on the output of the Wnt signalling pathway to answer the follow-
ing questions: Does nucleo-cytoplasmic shuttling of APC influence the [β-cat/TCF]
concentration, which is considered as the output of the pathway? Can the concen-
tration of [β-cat/TCF] benefit from APC shuttling? How is the output influenced
by cytoplasmic and nuclear retention of β-catenin by APC?
To answer these questions, I established a simple biochemical reaction network based
on experimentally obtained results, which describe the interactions and nucleo-
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cytoplasmic shuttling of β-catenin, the main protagonist of the canonical Wnt sig-
nalling pathway, and its antagonist APC. The network was translated into a ma-
thematical compartmental model based on ODEs. I assumed diffusive transport for
nuclear translocation of β-catenin. To examine the influence of nucleo-cytoplasmic
shuttling of APC on the output of Wnt signalling, I studied different shuttling mech-
anisms.
The analysis of the Retention Model led to the following results: The steady state
concentration of [β-cat/TCF] can be enhanced in response to nucleo-cytoplasmic
shuttling of APC. If the nuclear import rate constant of APC exceeds its export
rate constant, the accumulation of APC in the nucleus can cause a breakdown of
β-catenin retention by APC in the cytoplasm. As a consequence, free β-catenin ac-
cumulates in the cytoplasm and thus in the nucleus, which leads to a maximisation
of the transcription factor complex [β-cat/TCF] in contrast to a reference model
without APC shuttling. This effect is also visible if the nuclear concentration of
[β-cat/APC] is high due to enhanced binding affinity between the two proteins in
the nucleus. These findings thus show that Wnt signalling can benefit from nucleo-
cytoplasmic shuttling of APC.
I propose the following mechanism to explain this finding: In the Wnt-on state,
where β-catenin levels are high, β-catenin can cause phosphorylation of APC and
phosphorylated APC in the cytoplasm may retain β-catenin [Seo and Jho, 2007].
From their results, Seo and Jho [2007] concluded that this is to regulate excessive
[β-cat/TCF] signalling. My results, however, allow for an alternative interpreta-
tion as I additionally considered nucleo-cytoplasmic shuttling of APC: a high APC
shuttling ratio can lead to a breakdown of β-catenin retention in the cytoplasm,
therefore enhance nuclear accumulation of β-catenin and hence [β-cat/TCF] sig-
nalling. The breakdown of cytoplasmic retention by APC can even lead to an
enhanced [β-cat/TCF] concentration, if phosphorylated APC retains β-catenin in
the nucleus. This can be explained by a sufficiently high concentration of nuclear
β-catenin available to bind TCF. The inhibitory effect of APC is alleviated due to
shuttling of APC. In other words, this study indicates that the nucleo-cytoplasmic
shuttling of APC has a beneficial effect on the steady state output of the pathway,
although APC is an antagonising protein. Nucleo-cytoplasmic shuttling of antago-
nists may also play a relevant role in other pathways and the advantage it brings
may even be a general property in signalling.
Next, I investigated facilitated nuclear export of APC, which is based on a Michaelis-
Menten type rate law. I showed that maximal output of the [β-cat/TCF] concen-
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tration in steady state, which was obtained by considering diffusive shuttling of
β-catenin and APC, cannot be further increased by facilitated antagonist export.
My results demonstrate that it is possible to simulate the effects of saturated translo-
cation by pure diffusion. A difference in the shuttling rate constants of significant
orders of magnitude leads to an accumulation of the protein in the respective com-
partment. Based on this result, further modelling approaches of nucleo-cytoplasmic
shuttling, including the one presented in the following chapter, can be simplified.
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In this chapter I investigate the influence of nucleo-cytoplasmic shuttling of three
of the main β-catenin antagonists – the two scaffolding proteins APC and Axin
as well as the kinase GSK3 – on the output of Wnt/β-catenin signalling. For this
purpose, I establish a compartmental model, which is an extension of the Retention
model presented in Chapter 5. A detailed comparison of the two models is given
in the Chapter 7. One major difference between the two models is that in the Re-
tention Model only one β-catenin antagonist (namely APC) is considered. In this
model, the compartmental concentration of β-catenin was mainly regulated through
retention by APC. In contrast, I now regard the so-called destruction complex, con-
sisting of three β-catenin antagonists APC, Axin and GSK3. In the following the
destruction complex is referred to as AAG. As in this model β-catenin can not only
be retained but also degraded in both compartments, cytoplasm and nucleus, I re-
fer to it as the “Degradation Model”. Degradation is regarded as the principal
regulatory mechanism that controls the activity and hence nuclear accumulation of
β-catenin [Aberle et al., 1997]. The second major difference is that with this model
we can investigate the impact of different Wnt signals on the output of the system,
whereas the previously studied model was a closed system without any external
input or signal. In this chapter, I focus on the following questions: Does the nucleo-
cytoplasmic shuttling of β-catenin antagonists APC, Axin and GSK3 influence the
[β-catenin/TCF] concentration, which we consider as the output of Wnt signalling?
Can the [β-catenin/TCF] concentration be maximised by antagonist shuttling, lead-
ing to an optimised signal transduction through the cell? How is the output of the
pathway influenced by phosphorylation and subsequent degradation of β-catenin?
The construction of the Degradation Model is presented in Section 6.1. Similar to
the Retention model, the model structure is based on experimental findings which
are presented in Chapter 2. In Section 6.2, I investigate the influence of nucleo-
cytoplasmic antagonist shuttling and β-catenin degradation in the nucleus on the
[β-catenin/TCF] concentration. To this end, we (i) consider different Wnt on/off sce-
narios, (ii) investigate the impact of pathway inhibition and (iii) complete this study
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with a sensitivity analysis in order to quantify the robustness of the [β-catenin/TCF]
concentration against perturbations. A conclusion is given in Section 6.3. The con-
tent of this chapter is adapted from [Schmitz et al., 2013] and reproduced with
permission from Elsevier.
6.1. Construction of the Degradation Model
Figure 6.1 shows the reaction scheme of the biochemical network we study. The two
main components of the model are β-catenin, the main protagonist of the canonical
Wnt signalling pathway, and its antagonizing complex AAG. The protein β-catenin
and the complex AAG, distribute in both compartments, the cytoplasm and the
nucleus.
Reaction rates v1 and v2 describe translocation processes across the nuclear enve-
lope. β-catenin can interact directly with the nuclear pore complexes and can also
translocate on its own [Fagotto et al., 1998, Henderson and Fagotto, 2002, Wiechens
and Fagotto, 2001, Yokoya et al., 1999]. Note that the complex AAG as such is not
necessarily able to shuttle between cytoplasm and nucleus. However, its members
within their dissociated state are capable of nucleo-cytoplasmic shuttling [Bijur and
Jope, 2003, Caspi et al., 2008, Cong and Varmus, 2004, Franca-Koh et al., 2002,
Henderson, 2000, Krieghoff et al., 2006, Neufeld et al., 2000, Rosin-Arbesfeld et al.,
2000, Wiechens et al., 2004, Willert and Jones, 2006]. Therefore and for the sake of
simplicity, reaction rate v2 is summarising several steps: dissociation of the complex
into its parts (Axin, APC and GSK3), the translocation of the proteins Axin, APC
and GSK3, association of the proteins back into the destruction complex AAG. The
binding and dissociation steps are modelled in detail in the Lee model [Lee et al.,
2003]. Here, we neglect the dissociation and binding reactions of the destruction
complex and focus on the shuttling. However, in order to account for the multiple
reactions modelled by one step within the model, we constrain the reaction rate v2
in such a way that it is in both directions slow compared to v1 (we checked dif-
ferences of the order magnitude of 10 to 1000). The reaction rates v3, v4 and v5
describe binding and dissociation of β-catenin with/from AAG [Hart et al., 1998,
Kishida et al., 1998, Yost et al., 1996] in the cytoplasm and nucleus, and TCF,
respectively. β-catenin’s interaction with TCF can initiate transcription and can
therefore activate target gene expression [Behrens et al., 1996, Mosimann et al.,
2009]. The complex [β-catenin/TCF] is hence considered as the output of both, the
Wnt pathway and the Degradation Model. The arrows v6 and v7 describe the rates
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Figure 6.1.: Reaction scheme of the biochemical network. β-catenin and its antagonizing
destruction complex AAG are present in nucleus and cytoplasm. The involved proteins
are capable of nucleo-cytoplasmic shuttling. β-catenin can associate with AAG in the
cytoplasm and the nucleus, can then be phosphorylated by AAG, and subsequently
degraded by the proteasome. An incoming Wnt signal inhibits the destruction complex
in the cytoplasm. β-catenin is synthesised at constant rate. Complex formation with
TCF activates target genes and is considered as the output of the pathway. The reaction
rates are numbered 1 − 11 and in Table 6.1 the proteins and complexes are translated
into state variables (X1 to X11).
of two combined reactions: phosphorylation of β-catenin by the destruction com-
plex and the irreversible release of phosphorylated β-catenin from the destruction
complex (in cytoplasm and nucleus). Reactions v8 and v9 account for proteasomal
degradation of β-catenin [Aberle et al., 1997]. Synthesis of β-catenin is denoted as
v10 [Lee et al., 2003]. The arrows denoted with v11 represent the influence of Wnt
proteins: presence of a Wnt signal inactivates the destruction complex reversibly
(see [Lee et al., 2003] for a more detailed model). Therefore, reaction v11 combines
the inactivation with the counter reaction, i.e. the activation of AAG.
The biochemical reaction network depicted in Figure 6.1 is translated into a system
of coupled ordinary differential equations for further analysis. Each protein/protein
complex concentration is represented by a variable in the mathematical model (see
Table 6.1). Taking all described interactions into account, the dynamics of the
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biological system, i.e. the time-dependent changes of the concentrations of these
proteins and protein complexes, are determined by 11 coupled ODEs:
X˙1 = −ν1 − ν3 + ν10 X˙7 = −ν5
X˙2 = −ν2 − ν3 + ν6 − ν11 X˙8 = +ν5
X˙3 = +ν1 − ν4 − ν5 X˙9 = +ν6 − ν8
X˙4 = +ν2 − ν4 + ν7 X˙10 = +ν7 − ν9
X˙5 = +ν3 − ν6 X˙11 = +ν11
X˙6 = +ν4 − ν7 (6.1)
where the reaction rates νi on the right-hand side are functions of the protein or com-
plex concentrations, each one of them describing biochemical reactions or transport
processes:
ν1 = k1X1 − k−1X3 ν7 = k7X6
ν2 = k2X2 − k−2X4 ν8 = k8X9
ν3 = k3X1X2 − k−3X5 ν9 = k9X10
ν4 = k4X3X4 − k−4X6 ν10 = k10 = const.
ν5 = k5X3X7 − k−5X8 ν11 = k11W X2 − k−11X11
ν6 = k6X5 (6.2)
We assume all transport processes between the two compartments, nucleus and cy-
toplasm, to be purely diffusive. In Section 5.2.3, I have shown that it is possible to
model facilitated translocation of APC across the nuclear envelope as diffusion-like
motion. The effects of saturation can be simulated by using pure diffusion, if the
shuttling rate constants are chosen appropriately [Schmitz et al., 2011]. The index
of the shuttling constant is positive for transport into the nucleus and negative for
the transport back to the cytoplasm.
Binding and dissociation processes are described in the usual manner using mass-
action kinetics (see Section 3.3). The index of the respective constant is positive for
protein association and negative for protein dissociation. The degradation of phos-
phorylated β-catenin is modelled linearly and β-catenin is synthesised by a constant
rate. The Wnt signal can either be permanent or transient and is discussed in detail
in the Section 6.2.
Dissociation constants, reaction rate constants and total concentrations are set fol-
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State variable Original variable Interpretation
X1 β-catc free cytoplasmic β-catenin
X2 AAGc free cytoplasmic destruction complex
X3 β-catn free nuclear β-catenin
X4 AAGn free nuclear destruction complex
X5 [β-cat/AAG]c cytoplasmic complex [β-catenin/AAG]
X6 [β-cat/AAG]n nuclear complex [β-catenin/AAG]
X7 TCF free nuclear transcription molecules
X8 [β-cat/TCF] transcription complex [β-catenin/TCF]
X9 β-cat
p
c cytoplasmic phosphorylated β-catenin
X10 β-cat
p
n nuclear phosphorylated β-catenin
X11 AAGinactive inactive destruction complex
Table 6.1.: Definition of the state variables of the Degradation Model. Squared brackets
denote protein complexes. The indices n and c denote nuclear and cytoplasmic protein
concentrations, respectively, whereas p denotes a phosphorylated protein.
lowing the results of measurements and estimations conducted by the Kirschner
group in the Wnt-off state in Xenopus oocytes extracts [Lee et al., 2003], see Table
6.2. Recently, concentrations of Wnt pathway components have also been measured
for mammalian cells [Tan et al., 2012]. These values have been used to recalibrate
the Lee Model, see Section 4.6 for details. However, only initial concentrations have
been measured. To incorporate these new findings in this model, one would also need
reaction rate constants or dissociation constants. Therefore, I use the parameter val-
ues estimated and measured by Lee et al. [2003]. For the shuttling rate constants, I
do not use absolute values, but only shuttling rate constant ratios K1 = k−1/k1 and
K2 = k−2/k2, respectively. The shuttling rate constants are however constrained in
such a way that AAG shuttling is in both directions slow compared to β-catenin
shuttling, as discussed above. The parameter values for the transient Wnt signal
are discussed in Section 6.2.5.
The stoichiometry of the reaction scheme in Figure 6.1 implies the existence of two
conservation equations, which correspond to conserved numbers of proteins for the
destruction complex AAG and the transcription factor TCF. If more than one com-
partment is considered, like in this case, conservation sums can only be applied to
molecule numbers, not to concentrations (see Section 5.1.1). Assuming that com-
partment volumes and capacities are of the same size, the following expressions
exhibiting the double total concentrations A and T are obtained:
total AAG: 2A = X2 +X4 +X5 +X6 +X11 (6.3)
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total TCF: 2T = X7 +X8. (6.4)
In case of AAG, the total number of molecules is restricted by the limiting factor,
i.e. the amount of available Axin. It therefore equals A = 0.02 nM, whereas total
TCF equals T = 15 nM [Lee et al., 2003].
The total concentration of β-catenin is not conserved. It is denoted by B and
composed of the following:
total β-catenin: 2B = X1 +X3 +X5 +X6 +X8. (6.5)
According to the Lee model, total β-catenin equals B = 35 nM in the Wnt-off state.
This number serves as the initial value for the simulation experiments. In the Wnt-
on state the concentration of active β-catenin can yield much higher values.
For the reaction rate equations v3,v4 and v5, the quasi equilibrium is approached
rapidly, as shown by Lee et al. [2003]. This assumption leads to the dissociation
constants K3, K4 and K5, respectively. The model formulated above is investigated
in detail in the following section.
6.2. Results and discussion
Using the model developed in the previous section, I next investigate the impact of
nucleo-cytoplasmic antagonist shuttling and β-catenin degradation in the nucleus
on the [β-catenin/TCF] concentration. In a first step, I assume that the destruction
complex is only located in the cytoplasm. This system, which is referred to as the
reference model, forms the basis of this analysis. I then allow for nucleo-cytoplasmic
shuttling of the destruction complex and study its effect on the output of the path-
way. For this, I examine different scenarios in the Wnt-off state in order to provide
a comprehensive study of the model. I start by investigating the influence of β-
catenin destruction in the nucleus. In a second step, I study the impact of total
inhibition of the destruction complex by conducting knock-out experiments of all
involved reactions. This is done by setting the according reaction rate constants to
zero. In the second part of the analysis, the Wnt pathway is active. I first assume a
permanent Wnt signal, and then consider transient Wnt signalling. I complete the
results section by performing a sensitivity analysis to systematically investigate the
influence of parameter perturbation on the [β-catenin/TCF] concentration.
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Parameter name Default value Description
K3 120 nM Binding of β-catenin to AAG (cytoplasm)
K4 120 nM Binding of β-catenin to AAG (nucleus)
K5 30 nM Binding of β-catenin to TCF (nucleus)
k6 200 min
−1 Dissociation of [β-cat/AAG] into AAG and
phosphorylated β-catenin (cytoplasm)
k7 200 min
−1 Dissociation of [β-cat/AAG] into AAG and
phosphorylated β-catenin (nucleus)
k8 0.4 min
−1 Degradation of phosphorylated β-catenin
(cytoplasm)
k9 0.4 min
−1 Degradation of phosphorylated β-catenin
(nucleus)
k10 0.4 nM min
−1 Synthesis (rate) of β-catenin
k11 0.4 min
−1 Inactivation of the AAG
k12 0.2 min
−1 Activation of AAG
A 0.02 nM Total concentration of AAG (where Axin is
limiting)
T 15 nM Total concentration of TCF
B 35 nM Total initial concentration of β-catenin
λ 0.005 min−1 Reciprocal of the characteristic lifetime τWnt
of receptor stimulation
W0 10 Maximal stimulation (dimensionless)
Table 6.2.: The default parametrisation of the reference model based on Lee et al.
[2003]. Numeric values and description of the parameters of the reference model in its
default state. The parameters Ki = k−i/ki are dissociation constants. A,B, T illustrate
total protein concentrations. kj correspond to rate constants of the remaining involved
reactions. λ and W0 describe the shape of the transient Wnt signal.
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6.2.1. The reference model: Wnt-off and the antagonists are
only located in the cytoplasm
In Figure 6.2, the steady state concentration of [β-catenin/TCF] is presented in
dependence on the ratio of rate constants for β-catenin nucleo-cytoplasmic shuttling
(K1 =
k−1
k1
). For the reference model the shuttling rate constants of the destruction
complex are set to zero. I also set W = 0 and fix all other parameters according to
Table 6.2. The steady state dynamics of the reference model are illustrated as the red
curve in Figure 6.2. The steady states are obtained as follows: initially, the β-catenin
and its antagonists are located in the cytoplasm. During the simulation, β-catenin
will distribute in both, nucleus and cytoplasm, depending on the shuttling rate
constants k1 and k−1, while the antagonists will remain in the cytoplasm. The system
of ODEs (Equations (6.1)) is numerically integrated until the steady state solution
is reached for the Wnt-off state. This procedure is repeated for different shuttling
rate ratios K1 of β-catenin. Small values of K1 yield a higher concentration of [β-
catenin/TCF], because more β-catenin is located in the nucleus. Hence, the output
of the pathway is maximised, leading to an optimised transcriptional response of the
cell. The height of the plateau with a maximal [β-catenin/TCF] concentration of
approximately 30nM is essentially due to the value of the corresponding dissociation
contant K5 = 30nM.
For K1 = 1, the [β-catenin/TCF] concentration equals approximately 11 nM. In
the Wnt-off state of the Lee Model [Lee et al., 2003, Page 121], the value of [β-
catenin/TCF] equals 6.83nM. Comparing the two numbers, we see that they differ
by a factor of almost two. This is due to the fact that concentrations are regarded,
which are naturally related to the size (volume) of the respective compartment. In
this model, two compartments of equal size are considered, whereas the Lee Model
only consists of one compartment of the same total volume. Therefore, the steady
state concentration of [β-catenin/TCF] in the Wnt-off state of the two models should
differ by a factor of two and are therefore in good agreement. Next, I consider nucleo-
cytoplasmic shuttling of AAG and also include phosporylation and degradation of
β-catenin in the nucleus.
6.2.2. Wnt-off and destruction complex formation in the nucleus
In this section, I investigate the effects of nucleo-cytoplasmic antagonist shuttling
and destruction of phosphorylated β-catenin in the nucleus on the steady state con-
centration of [β-catenin/TCF] in the Wnt-off state. For this, I consider different
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Figure 6.2.: Steady state levels of the [β-catenin/TCF] concentration for different shutt-
ling rate constants ratios of β-catenin (K1, see x-axis) and the destruction complex (K2,
see legend) in the Wnt-off state. The tags x specify the values for the shuttlings ratios
we focus on for the sensitivity analysis. For further information on the tagged positions
as well as the yellow box please refer to Section 6.2.6.
ratios of shuttling rate constants of AAG (K2 =
k−2
k2
from 100 to 0.01). Again, the
steady state values are obtained using simulation. The parameters are set accord-
ingly (Table 6.2). The results are also depicted in Figure 6.2.
In general, the shapes of the curves are similar. However, the curves are shifted by
extent along the x-axis and also compressed along the y-axis such that they inter-
sect in one specific point K ′1 = 1. For K1 < K
′
1, the steady state concentration of
[β-catenin/TCF] is smaller, if the shuttling rate constant ratio of AAG is smaller
and hence more AAG is located in the nucleus. The maximum value of the refer-
ence case ‘no shuttling’ (red curve) cannot be exceeded. For small values of K1,
most β-catenin is located in the nucleus. In this case, a higher concentration of
[β-catenin/TCF] is obtained if the destruction complex remains in the cytoplasm,
because cytoplasmic AAG and nuclear TCF cannot compete for β-catenin binding
directly.
For K1 > K
′
1, however, more β-catenin is located in the cytoplasm than in the
nucleus. In this case we see that the concentration of [β-catenin/TCF] can be in-
creased due to nucleo-cytoplasmic shuttling of β-catenin antagonists in comparison
to the previously discussed reference model. For decreasing values of K2, which
corresponds to an increasing nuclear concentration of AAG, the concentration of
[β-catenin/TCF] increases significantly, compared to the reference model without
AAG shuttling. Therefore, nucleo-cytoplasmic shuttling of β-catenin antagonists
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can increase the output of Wnt signalling.
This increase can be explained as follows: For high values of K1, most β-catenin
is located in the cytoplasm, whereas for small values of K2, most AAG is located
in the nucleus. This separation into two different compartments prevents β-catenin
from interacting with the destruction complex. Hence, most β-catenin remains
free and unbound in the cytoplasm, whereas the cytoplasmic concentration of [β-
catenin/AAG] is minimal. Thus, β-catenin cannot be degraded and therefore cy-
toplasmic β-catenin levels increase. This in turn means that more β-catenin can
translocate into the nucleus, which leads to an increase of the [β-catenin/TCF] con-
centration.
To sum up, I conclude that on the left side (K1 < K
′
1) of Figure 6.2 the phosphoryla-
tion and subsequent destruction of β-catenin in the nucleus is dominantly influencing
the maximal levels of the curves. Thus, the destruction of nuclear β-catenin by AAG
is reducing the [β-catenin/TCF] levels. On the right side of Figure 6.2, however, the
effects of the processes that occur in the cytoplasm are dominant. The breakdown
of degradation of cytoplasmic β-catenin leads to higher levels of total β-catenin
and hence to maximised [β-catenin/TCF] concentration. In both cases, the sepa-
ration of β-catenin and AAG in two different compartments leads to an increase
of the steady state concentration of [β-catenin/TCF]. Counterintuitively, these re-
sults provide therefore evidence that nucleo-cytoplamic shuttling of the members
of the destruction complex can yield a maximisation of [β-catenin/TCF] signalling.
In spite of being β-catenin antagonists and thus actively reducing β-catenin levels,
they are still capable of positively influencing the output of the pathway. To provide
a comprehensive analysis of the model, we next investigate the maximal impact of
the activity of the destruction complex in the cytoplasm and the nucleus, by inde-
pendently inhibiting the involved reactions.
6.2.3. Wnt-off and the impact of total inhibition
In order to investigate the maximal influence of the degradation of β-catenin in the
cytoplasm and the nucleus on [β-catenin/TCF] signalling, we independently inhibit,
i.e. knock-out, all reactions related to the activity of the destruction complex. From
cancer drug development it is known that possible targets for inhibitors include β-
catenin protein-protein interactions and the involved kinases [Polakis, 2012]. We
here, however, focus on pathway output maximisation, rather than Wnt inhibition,
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since this yields an optimised transcriptional activity of the cell. The key question
remains whether [β-catenin/TCF] concentration can be maximised by antagonist
shuttling. I consider the Wnt-off state, the results are however similar for the Wnt-
on state (W = 1, data not shown). I focus on the reactions concerning the activity
of the destruction complex (see Figure 6.1), namely the binding of β-catenin to
the destruction complex in the cytoplasm (ν3) and in the nucleus (ν4), as well as
the activity of GSK3, which causes the phosphorylation of β-catenin and release of
phosphorylated β-catenin from the destruction complex in the cytoplasm (ν6) and
the nucleus (ν7). All interactions are inhibited independently of each other in order
to investigate the maximal influence of intervention. Inhibiting the kinase in both
compartments, cytoplasm and nucleus, at once, would lead to a model structure we
have analysed before (the Retention Model, see Chapter 5). Inhibiting the binding
processes of AAG and β-catenin in both compartments at once, leads to a model
structure where β-catenin is not interacting with any molecule, except TCF, and is
hence trivial.
The effects of the inhibition of β-catenin–AAG binding and of the activity of
the kinase GSK3 on the steady state concentration of [β-catenin/TCF] in the cy-
toplasm are depicted in the top row of Figure 6.3. In the left panel, the binding
of β-catenin to the destruction complex is inhibited in the cytoplasm. Compared to
the reference model discussed in Section 6.2.1, see Figure 6.2, the curves are shifted
along the x-axis to a different extent, such that higher values of [β-catenin/TCF] are
obtained for shuttling ratios of K1 > 1, where more β-catenin is located in the cyto-
plasm. Therefore, the inhibition of the destruction complex in the cytoplasm leads
to an increase of the [β-catenin/TCF] concentration, because more free β-catenin
is available to bind TCF. This increase is particularly significant for higher shutt-
ling ratios of K2, causing more AAG to be located in the cytoplasm (black and red
curves). The more AAG is located in the nucleus, the higher the effect of phosphory-
lation and hence inactivation of β-catenin by the destruction complex. Accordingly,
the levels of [β-catenin/TCF] are decreasing for decreasing AAG shuttling constant
ratio K2, compared to the ‘no shuttling’ (red) curve with inhibited cytoplasmic
binding.
In the right panel of the top row, the kinase activity leading to the degradation of
cytoplasmic β-catenin by the destruction complex is inhibited. Hence, AAG is still
able to bind and retain β-catenin, but not to further process, i.e. phosphorylate and
degrade, it. Therefore, the complex can only release β-catenin in its active state.
Interestingly, the output concentration of [β-catenin/TCF] is even more increased
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Figure 6.3.: Steady state levels of the [β-catenin/TCF] concentration for different inhi-
bition scenarios and different shuttling rate constants ratios of β-catenin (x-axis) and
the destruction complex (see legend). Top row, left panel: Binding of β-catenin to the
destruction complex is inhibited in the cytoplasm (ν3 = 0). Top row, right panel: Phos-
phorylation and degradation of β-catenin by the destruction complex is inhibited in the
cytoplasm (ν6 = 0). Bottom row, left panel: Binding of β-catenin to the destruction
complex is inhibited in the nucleus (ν4 = 0). Bottom row, right panel: Phosphoryla-
tion and degradation of β-catenin by the destruction complex is inhibited in nucleus
(ν7 = 0).
due to nucleo-cytoplasmic shuttling of AAG in comparison to the previously dis-
cussed case where complex formation of AAG and β-catenin was inhibited (top row,
left panel), if K2 = 1 (blue curve). The effect is also visible for K2 = 0.1 to 10. The
mechanism that leads to this increase is based on a combination of β-catenin reten-
tion and degradation: if in this parameterisation, AAG is only or mainly located
in the cytoplasm (red and black curves), and β-catenin is located in the nucleus,
β-catenin levels are high, because of the compartmental separation of β-catenin and
AAG. If most AAG is in the nucleus (magenta curve), the competition of AAG and
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TCF for β-catenin binding reduces the [β-catenin/TCF] concentration. If, however,
AAG is distributed in both, cytoplasm and nucleus (green and blue curves), cyto-
plasmic AAG is retaining β-catenin (and vice versa) in the cytoplasm and thereby
prevents it from being degraded by the destruction complex in the nucleus. Con-
currently, the concentration of the destruction complex in the nucleus is reduced
and hence the output concentration of [β-catenin/TCF] is enhanced. Therefore, the
inhibition of the cytoplasmic kinase activity is leading to β-catenin degradation in
the nucleus, and β-catenin/AAG retention in the cytoplasm, and thereby yields an
increased [β-catenin/TCF] concentration.
Next, we independently inhibit the binding of β-catenin to the destruction com-
plex and the activity of the kinase GSK3 in the nucleus, respectively. The effects of
these inhibitions on the steady state concentration of [β-catenin/TCF] are presented
in the bottom row of Figure 6.3. In the left panel, the binding of β-catenin to the
destruction complex is inhibited in the nucleus. In this case, the curves are again
shifted, but not only in direction of the x-axis; for small values of K2 the curves
are also visibly shifted along the y-axis, such that a much higher concentration for
[β-catenin/TCF] is obtained due to nucleo-cytoplasmic shuttling of AAG in com-
parison to the reference model (see Figure 6.2). The mechanism that leads to this
increase is closely related to the one we have previously discussed in Section 6.2.2:
For high values of K1 and small values of K2, β-catenin and AAG are separated into
two different compartments, which prevents β-catenin from interacting with the de-
struction complex. Hence, cytoplasmic β-catenin levels increase and more β-catenin
translocates into the nucleus. This leads to a [β-catenin/TCF] concentration, which
is enhanced in comparison to the model with active destruction complex. In this
case, TCF is not competing with AAG for β-catenin binding, due to the inhibited
binding ability of the destruction complex.
In the right panel of the bottom row of Figure 6.3, the activity of the kinase GSK3,
and hence degradation of β-catenin by the destruction complex, is inhibited in the
nucleus. However, AAG is still able to bind and thus retain β-catenin. Surpris-
ingly, both types of inhibitions lead to almost identical steady state concentrations
of [β-catenin/TCF]. This is due to the very small concentration of AAG (0.02 nM in
total, limited by the Axin concentration [Lee et al., 2003], see Table 6.2) in compar-
ison to the concentration of β-catenin. Therefore, the fraction of retained β-catenin
is too small to make a visible difference. In summary, we show that inhibition of
the destruction complex is enhancing the [β-catenin/TCF] concentration and hence
the output of the pathway. Unexpectedly, given the premise that APC, Axin and
73
6. The Degradation Model
GSK3 are able to translocate into the nucleus, these results strongly suggest that
the [β-catenin/TCF] concentration is more effectively enhanced by inhibiting the
activity of the kinase GSK3 rather than the binding of β-catenin to the destruction
complex. There are many GSK3 inhibitors known and available, with lithium be-
ing the best-characterized, although fairly specific for GSK3 [Doble and Woodgett,
2003]. However, several new inhibitors have recently been developed with different
mode of actions and therapeutical potential [Cohen and Goedert, 2004, Doble and
Woodgett, 2003].
So far, I focussed on the Wnt-off state of the pathway. In the following sections, I
consider permanent and transient Wnt signals and investigate their impact on the
[β-catenin/TCF] concentration especially with respect to changes in β-catenin and
AAG nucleo-cytoplasmic shuttling.
6.2.4. The influence of a permanent Wnt signal
In previous sections 6.2.1 to 6.2.3, I investigated the impact of nucleo-cytoplasmic
antagonist shuttling on the [β-catenin/TCF] concentration in the Wnt-off state. In
the present section, I examine the influence of a permanent Wnt signal on the [β-
catenin/TCF] concentration, in order to provide a comprehensive analysis of the
Degradation Model. By applying permanent Wnt signals of different strengths, I
ascertain the maximal influence of these Wnt signals on the output of the pathway
by determining the according new steady state solutions. Wnt signalling yields an
inactivation of the destruction complex and is therefore critical for the concentration
of the key protein β-catenin in the cell (see Figure 2.2). As shown in Figure 6.1,
I assume that the Wnt signal (W > 0) can only inhibit the destruction complex
in the cytoplasm, not in the nucleus, as Wnt binds the receptors in the cell mem-
brane. In the presence of Wnt ligands, the destruction complex is recruited to the
Wnt-receptor complex and subsequently inactivated (see Section 2.2). I assume that
the spatial distance from the membrane to the inner nucleus prevents the destruc-
tion complex from being inactivated while it is located in the nucleus. Steady state
levels of the [β-catenin/TCF] concentration for permanent Wnt stimuli of increas-
ing strength are presented in Figure 6.4 (top left: W = 1, top right: W = 10,
bottom left: W = 100, bottom right: W = 1000). We see that the influence of
a growing permanent Wnt signal is visible in the shift of the curves along the x-
and y-axes and hence the intersection point of the curves: For W = 1 (top left
panel of Figure 6.4, the intersection point at K ′1 is shifted towards a higher shutt-
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Figure 6.4.: Steady state levels of the [β-catenin/TCF] concentration for different per-
manent Wnt stimuli levels given in arbitrary dimensionless units (top left: W = 1, top
right: W = 10, bottom left: W = 100, bottom right: W = 1000). The [β-catenin/TCF]
steady state concentrations are plotted in dependence of different shuttling rate con-
stants ratios of β-catenin (x-axis) and the destruction complex (see legend).
ling rate constant ratio of β-catenin compared to the Wnt-off state presented in
Figure 6.2. For further increased strength of the Wnt signal (W =10, 100, 1000),
the intersection point shifts even further towards higher values of K1. Thereby, the
concentration of [β-catenin/TCF] increases for larger shuttling rate constant ratios
of β-catenin and smaller shuttling rate constant ratios of the destruction complex.
As expected these results confirm that a weak Wnt signal only reduces the effect of
cytoplasmic degradation (right hand side of the intersection point). The impact of
nuclear degradation on the output of the pathway (left hand side of the intersection
point) is only significantly reduced at much stronger Wnt signals. For very strong
Wnt signals almost all the AAG is present in its inactivated/inhibited state. This
leads to a higher concentration of free β-catenin and hence a higher concentration
of [β-catenin/TCF] for higher values of K1 and smaller values of K2. Accordingly,
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I conclude that the impact of antagonist shuttling on the [β-catenin/TCF] output
becomes weaker with an increasing Wnt signal.
6.2.5. A transient Wnt signal
In the previous section, I examined the impact of a permanent Wnt signal of differ-
ent strengths on the [β-catenin/TCF] concentration. We have thereby seen that a
very strong Wnt signal reduces the influence of AAG shuttling notably. In vivo how-
ever, Wnt stimulation is transient, likely due to receptor inactivation/internalization
and/or other downregulatory processes [Lee et al., 2003]. Transient activation of the
Wnt pathway is modelled assuming a Wnt stimulus that decays exponentially:
W (t) =

0 , for t < t0
W0 e
−λ(t−t0) , for t ≥ t0
(6.6)
where λ is the reciprocal of the characteristic lifetime of receptor stimulation [Lee
et al., 2003], t0 denotes the onset of signalling and W0 is the initial stimulation of
the pathway. Parameter values are chosen arbitrarily and given in Table 6.2.
I first discuss the trajectories of the involved proteins and protein complexes during
a transient Wnt signal for K1 = 0.1 and different AAG shuttling ratios (K2) and
afterwards compare and discuss the trajectories of the [β-catenin/TCF] for varying
shuttling ratios for β-catenin during the same transient Wnt signal (K1 = 0.1,1 and
10). The results of the simulations are presented in Figures 6.5 and 6.6, respectively.
Before I consider a transient Wnt signal, the system is first simulated in the Wnt-off
state, until the steady state has been reached. Then the Wnt signal is switched
on according to Equation (6.6). With off-fading Wnt signal, the system again ap-
proaches the Wnt-off steady state.
Figure 6.5 shows the trajectories of the β-catenin and AAG concentrations in
the cytoplasm (cyto) and the nucleus (nuc), as well as the output concentration
[β-catenin/TCF] during a transient Wnt signal in dependence of the shuttling rate
constants of the destruction complex. In this parameterisation (K1 = 0.1), more
β-catenin is present in the nucleus than in the cytoplasm. We see that during the
Wnt signal the concentration of inactive AAG quickly reaches a maximum (Figure
6.5g). The more AAG is available in the cytoplasm, the higher the value of maximal
inactive AAG (red, black lines). For K2 = 0.01 (magenta lines), the Wnt signal has
hardly any effect on the concentration of AAG, as most AAG is located in the nu-
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Figure 6.5.: Trajectories of protein and protein complex concentrations during a tran-
sient Wnt signal for K1 = 0.1 and different shuttling rate constants ratios for the de-
struction complex (K2, see legend). In the simulation, the steady state is first reached
in the Wnt-off state, before the transient Wnt signal is applied to the system. The
simulation time is given on the x-axis of each subfigure. The state variable/protein
concentration in the cytoplasm (cyto) and nucleus (nuc) is given on the y-axis.
cleus and Wnt can only inhibit cytoplasmic AAG. Concurrently, the concentrations
of active AAG reach a minimum (in cytoplasm and nucleus, Figure 6.5b+e). The
inactivation of AAG is followed by an increase of total β-catenin (Figure 6.5h). This
is attended by an increase of free β-catenin, in the cytoplasm (Figure 6.5 a) as well
as in the nucleus (Figure 6.5d). Interestingly, the concentration of [β-catenin/AAG]
first reaches a minimum, followed by a maximum, before it approaches the Wnt-
off steady state again. This behaviour can be observed in the cytoplasm (Figure
6.5c) as well as in the nucleus (Figure 6.5f). This is due to the high amounts of
total β-catenin during the Wnt signal (Figure 6.5h), which can bind (re-)activated
AAG with decreasing Wnt stimulus. Increased levels of [β-catenin/AAG] are only
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of short duration until most of the free β-catenin is phosphorylated by the destruc-
tion complex and subsequently degraded by the proteasome. After the Wnt signal,
β-catenin levels are kept low in the Wnt-off state due to continuous degradation.
The dynamics of the [β-catenin/TCF] concentration (see Figure 6.5i) in principal
follow the dynamics of the total β-catenin (Figure 6.5h) for the different shuttling
rate constants ratios of AAG. We see the expected increase of the [β-catenin/TCF]
concentration with the onset of the Wnt signal, but in contrast to the β-catenin dy-
namics, we observe a maximal peak for K2 = 1 (blue curve). Thus, these simulation
results predict that balanced nucleo-cytoplasmic shuttling of AAG can increase the
output of the pathway in relative response to a transient Wnt signal.
I now compare the results for the trajectories of the [β-catenin/TCF] in this pa-
rameterisation for β-catenin shuttling (K1 = 0.1, i.e. more β-catenin is located in
the nucleus, shown in Figure 6.5 i) with the results depicted in Figure 6.6, where
K1 = 1 (left plot) and K1 = 10 (right plot), respectively. Remember that the
different basal levels (just before the on-set of the Wnt signal) correspond to the
different Wnt-off steady state concentrations for the different K1 parameter values.
I relate the peak of the transient Wnt signal to the basal steady state levels, and
hence consider the relative response of the [β-catenin/TCF] concentration to the
Wnt signal [Cohen-Saidon et al., 2009].
We see that in the three scenarios, different shuttling rate constant ratios of AAG
yield maximal relative response of the [β-catenin/TCF] concentration during tran-
sient Wnt signalling, but that this maximal response does not necessarily correspond
to maximal absolute levels of [β-catenin/TCF]:
As stated above, for K1 = 0.1, the blue curve (K2 = 1) shows maximal relative
response to Wnt signalling. In this case the output increases from 15 nM to 22
nM (see Figure 6.5i). The maximal absolute concentration is, however, obtained
for the red curve, where AAG cannot translocate into the nucleus, although in this
case the [β-catenin/TCF] concentration is hardly responding to Wnt signalling at
all. For K1 = 1 (Figure 6.6, left panel), the ‘no shuttling’ (red) curve also exhibits
maximal relative responses to Wnt signalling and also exhibits a maximal absolute
[β-catenin/TCF] concentration of 20 nM. Contrariwise, for K1 = 10 (Figure 6.6,
right panel), the ‘no shuttling’ case reveals maximal relative response to Wnt sig-
nalling, but yields minimal output compared to the other AAG shuttling parameter
values. Here, maximal output is obtained for K2 = 0.01 (magenta curve), where
most AAG is located in the nucleus.
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Figure 6.6.: Trajectories of the [β-catenin/TCF] concentration during a transient Wnt
signal for different shuttling rate constants ratios for the destruction complex (K2, see
legend) and β-catenin (left panel: K1 = 1, right panel: K1 = 10). In the simulation,
the steady state is first reached in the Wnt-off state, before the transient Wnt signal is
applied to the system.
To sum up, we see very divers responses to the Wnt signal depending on the cellular
distribution of β-catenin and AAG, which is primarily determined by the nucleo-
cytoplasmic shuttling ratios. However, I want to highlight two major outcomes of
my analysis: first, these results indicate that for a high β-catenin concentration in
the nucleus (Figure 6.5i), which is very likely to be the case in the on-state of the
pathway, well-balanced AAG shuttling leads to the maximal relative response to
Wnt signalling. This finding is unexpected and yet promising, as the underlying
relations between the shuttling ratios and concentrations of β-catenin and AAG can
be used to design experiments in order to efficiently manipulate the cells such that
the [β-catenin/TCF] concentration is maximised.
Second, the results for a transient Wnt signal confirm what we discovered with re-
spect to permanent signalling: the transient Wnt signal has a bigger impact on the
[β-catenin/TCF] concentration if more AAG is located in the cytoplasm. In all three
scenarios I investigated, the magenta curves, which correspond to an increased nu-
clear AAG concentration, show minimal response to transient Wnt signalling. From
this result I conclude that nucleo-cytoplasmic shuttling of AAG renders the path-
way robust against fluctuations in Wnt signalling. Thus, a threshold concentration
of Wnt ligands and a minimal duration of the Wnt Signal is needed to overcome
the influence of the nuclear destruction complex against background fluctuations of
Wnt.
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So far, I investigated the impact of the shuttling parameters and of Wnt signalling
on the output of the pathway. However, it is interesting to quantify the sensitivity
of the system’s output towards changes or perturbations of not only the shuttling
parameters, but also towards individual perturbations of all involved parameters.
This provides us with the opportunity to directly compare the sensitivities, and ad-
ditionally to determine the total robustness of the [β-catenin/TCF] concentration
with respect to perturbations of all parameters. In the next section, I therefore
conduct a sensitivity analysis of the [β-catenin/TCF] concentration for a transient
Wnt signal.
6.2.6. Time dependent sensitivity analysis for a transient signal
One goal of this chapter is to provide a comprehensive study of the Wnt signalling
pathway with respect to β-catenin degradation and nucleo-cytoplasmic shuttling of
β-catenin itself as well as its antagonists. Similar to the Lee Model, the Degradation
Model contains several parameters that affect the output of the system in different
ways and to various extent. In order to account for the robustness of the system
against perturbations, one widely used tool is the so-called sensitivity analysis. In
this section, I perform a sensitivity analysis to systematically investigate the pertur-
bation of which parameter is influencing the [β-catenin/TCF] concentration most
dramatically. For quantifying the effects of the perturbations, I calculate control
coefficients, as defined in Section 3.4.3.
The control coefficients are calculated according to Equation (3.7) at discrete time-
points during the course of a transient Wnt signal, which is described with Equa-
tion 6.6. For the last time-point, the system has returned to its steady state. I
focus on [β-catenin/TCF] and calculate the responses of the concentration of this
compound upon changes of about ±1% in the rate constants of all parameters kj
involved in the network.
We perform the analysis at different positions in parameter space for the shuttling
rate constants ratios. In particular, we focus on K1 = 0.1, 1 and 10 and K2 = 0.01,
1 and ‘no AAG shuttling’ (which corresponds to k2 = 0, hence all AAG is present in
the cytoplasm). Accordingly, we end up with nine sets of results for 19 perturbed
parameters each. All results are presented in Appendix A, Figures A.1 - A.9.
In general, the parameters that effect the system most efficiently are k5 and k−5,
describing the binding and dissociation of β-catenin and TCF, and k10, which ac-
counts for β-catenin synthesis. These parameters have a major impact on the [β-
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AAG vs. β-cat shuttling K1 = 0.1 K1 = 1 K1 = 10
K2 : no shuttling (red) 4.70 26.65 58.72
K2 = 1 (blue) 21.44 29.50 55.53
K2 = 0.01 (magenta) 26.38 26.24 27.12
Table 6.3.: Quantified total robustness. Sums of the control coefficients. We consider
the absolute values of the control coefficients for a parameter perturbation of +1%
over all time points and all parameters for different shuttling rate constant ratios. The
according positions in parameter space are tagged in Figure 6.2. The colours given with
K2 correspond to the curves presented in Figure 6.2.
catenin/TCF], because the ratio of k−5 to k5 directly describes the binding affinity
of β-catenin and TCF and the synthesis rate k10 determines the amount of produced
and hence the available β-catenin.
The other parameters that have a significant influence on the [β-catenin/TCF] con-
centration depend on the parametrisation and hence the compartmental distribution
of AAG and β-catenin. Therefore, either the control coefficients of k3, k−3 and k6
(activity of the destruction complex in the cytoplasm) or k4, k−4 and k7 (activity of
the destruction complex in the nucleus) exhibit larger values. In contrast to the Lee
model, where the control coefficients of binding and dissociation parameters sum
up to zero [Lee et al., 2003], we here observe that the control coefficients of k−3
(dissociation rate constant of AAG and β-catenin) and k6 (constant that describes
phosphorylation of β-catenin and irreversible release of phosphorylated β-catenin)
sum up to zero. This applies analogously to k−4 and k7 and therefore holds true for
these processes in both compartments, cytoplasm and nucleus.
In order to quantify the total sensitivity of the system, I sum up the absolute
values of the control coefficients over all time-points for each parameter (for a per-
turbation of +1%; red dots in Figures A.1 - A.9, Appendix A). The results are
shown in Subfigure 20 in each of the supplementary figures. Subsequently, I add up
these temporal sums over all parameters. I thereby arrive at nine sums of control
coefficients for different shuttling ratio pairs (K1, K2), which are presented in Table
6.3. These sums are considered as the quantification of the total robustness, where
small numbers correspond to high robustness. The according positions in parame-
ter space are tagged in Figure 6.2. The tagged concentrations of [β-catenin/TCF]
correspond to the steady state concentrations just before the transient Wnt signal
is applied to the system, which of course equals the steady state the system reaches
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after the transient signal. Relating the numbers presented in Table 6.3 to Figure 6.2,
we see that the total robustness is linked to the output levels of [β-catenin/TCF]:
for high [β-catenin/TCF] levels in steady state (K1 = 0.1 and no AAG shuttling),
where all AAG is located in the cytoplasm and most β-catenin is in the nucleus,
the system exhibits the most robust output [β-catenin/TCF] (

C = 4.70). This
is due to the fact that if β-catenin and its antagonists reside in different compart-
ments, and hence cannot interfere with each other. Unexpectedly, these results
therefore reveal that the compartmental separation of β-catenin and the destruc-
tion complex does not only lead to a maximisation of [β-catenin/TCF], but also to
an increased robustness of [β-catenin/TCF] signalling. On the other hand, when
the [β-catenin/TCF] concentration is small (K1 = 10, no AAG shuttling) and both,
AAG and β-catenin, are mostly located in the cytoplasm, the system is the least
robust to parameter perturbations (

C = 58.72). Consequently, in this case the
[β-catenin/TCF] concentration reacts most sensitive towards cellular modifications.
This, however, could also be of advantage, because already weak signals may trigger
the on-set of signalling, helping the system to quickly adapt to changes in its cellular
environment.
For intermediate levels of [β-catenin/TCF] (highlighted with a yellow box in Fi-
gure 6.2), the system exhibits intermediate levels of robustness. Here, the total
robustness sums equal values between 26 and 30. Provided that AAG is not able to
translocate into the nucleus (red line in Figure 6.2, and first line in Table 6.3), we
furthermore observe the largest and the smallest value for the total robustness of
the [β-catenin/TCF] concentration for the studied β-catenin shuttling rate ratios,
indicating that the system’s robustness is highly dependent on β-catenin’s shutt-
ling ratio. If, however, the destruction complex is present and active in the nucleus
(magenta line in Figure 6.2, and bottom line in Table 6.3), the total sensitivity of
the [β-catenin/TCF] concentration remains almost the same for all β-catenin shutt-
ling scenarios. From this I deduce that if most β-catenin is present in the nucleus,
AAG shuttling acts sensibilising on the [β-catenin/TCF] concentration. In con-
trast, if most β-catenin is located in the cytoplasm, nucleo-cytoplasmic shuttling of
the destruction complex does not only yield higher levels [β-catenin/TCF], but the
[β-catenin/TCF] output concentration is also more robust against perturbations in
general. From this analysis, I therefore conclude that AAG shuttling, which causes
a higher nuclear AAG concentration, results in a [β-catenin/TCF] output that is
especially robust against changes in the compartmental distribution of β-catenin.
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6.3. Conclusions
In this chapter, I established a novel compartmental model of Wnt pathway to inves-
tigate the influence of nucleo-cytoplasmic shuttling of β-catenin and its antagonists
APC, Axin and GSK3, on the [β-catenin/TCF] concentration. In order to provide
a comprehensive analysis, I conducted several case studies: (i) I considered different
Wnt on/off scenarios, (ii) I investigated the impact of pathway inhibition and (iii)
I completed my study with a sensitivity analysis. The investigation addressed the
following concrete questions: Does the nucleo-cytoplasmic shuttling of β-catenin an-
tagonists influence the [β-catenin/TCF] concentration? Can the [β-catenin/TCF]
concentration be maximised by antagonist shuttling, leading to an optimised signal
transduction through the cell? How is the output of the pathway influenced by
phosphorylation and subsequent degradation of nuclear β-catenin?
My analysis revealed the following key findings: Nucleo-cytoplasmic shuttling of
the destruction complex AAG can yield a spatial separation of β-catenin and AAG
into cytoplasm and nucleus. This separation can prevent β-catenin from inter-
acting with the destruction complex, and thus causes a breakdown of β-catenin
degradation. Subsequently, levels of total β-catenin are enhanced and this hence
results in an increase of the steady state concentration of the transcription fac-
tor complex [β-catenin/TCF]. My results provided therefore unexpected evidence
that nucleo-cytoplamic shuttling of the destruction complex can yield a maximi-
sation of [β-catenin/TCF] signalling in comparison to a reference model without
AAG shuttling. In spite of being β-catenin antagonists and thus actively reducing
β-catenin levels, these findings demonstrate that Wnt signalling can benefit from
nucleo-cytoplasmic shuttling of AAG.
Another objective of my analysis was to elucidate the impact of destruction complex
inhibition. The results of my analysis support the expectation that inhibition of the
destruction complex is enhancing the [β-catenin/TCF] concentration and hence the
output of the pathway. Unexpectedly, given the premise that the destruction com-
plex is assembled in the nucleus, I showed that the [β-catenin/TCF] concentration is
more effectively enhanced by inhibition of the kinase GSK3 rather than the binding
of β-catenin to the destruction complex. There are many GSK3 inhibitors known
and available, with lithium being the best-characterized, although fairly specific
for GSK3 [Doble and Woodgett, 2003]. Recently, several new inhibitors have been
developed [Cohen and Goedert, 2004, Doble and Woodgett, 2003], offering various
possibilities for experimental intervention.
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Next, I studied the influence of permanent and transient Wnt signals. The results in
this regard confirmed the intuitive assumption that a weak permanent Wnt signal
only reduces the effect of cytoplasmic β-catenin degradation, as Wnt only causes
the dissociation of the destruction complex if it is located in the cytoplasm. For an
increased nuclear AAG concentration, however, [β-catenin/TCF] signalling exhibits
minimal response to Wnt. From this result, I conclude that nucleo-cytoplasmic
shuttling of AAG renders the pathway robust against fluctuations in Wnt signalling.
Thus, a threshold concentration of Wnt ligands and a minimal duration of the Wnt
Signal is needed to overcome the influence of the nuclear destruction complex against
background fluctuations of Wnt. Furthermore, simulation experiments revealed very
diverse responses of [β-catenin/TCF] to transient Wnt signalling. The response de-
pends on the cellular distribution of β-catenin and AAG, which is primarily deter-
mined by the nucleo-cytoplasmic shuttling ratios. In particular, for a high β-catenin
concentration in the nucleus, well-balanced AAG shuttling yields maximal relative
response to Wnt signalling. This is very likely to be the case in the on-state of the
Wnt pathway. This finding is both, unexpected and yet promising, as the underlying
relations between the shuttling ratios and concentrations of β-catenin and AAG can
be used to design wet-lab experiments in order to efficiently manipulate the cells
such that the [β-catenin/TCF] concentration is maximised.
In complete this study, I conducted a sensitivity analysis to systematically inves-
tigate the influence of parameter perturbations on the [β-catenin/TCF] concen-
tration. Surprisingly, my results demonstrated that the total robustness of the
[β-catenin/TCF] output is closely linked to its absolute concentration levels. The
system exhibits the most robust [β-catenin/TCF] concentration, if β-catenin and
its antagonists cannot interfere with each other. This is the case when they re-
side in different compartments, which is due to nucleo-cytoplasmic shuttling. These
findings therefore revealed that the compartmental separation of β-catenin and the
destruction complex does not only lead to a maximisation, but additionally to an in-
creased robustness of the [β-catenin/TCF] concentration. Contrariwise, if AAG and
β-catenin are mostly located in the cytoplasm, the concentration of [β-catenin/TCF]
is very low. In this case, I proved the [β-catenin/TCF] concentration to be very sen-
sitive to parameter perturbations and thus to react most sensitive towards intracel-
lular modifications. This could also be of advantage, since for low [β-catenin/TCF]
concentrations weak signals may already trigger the activation of the pathway, help-
ing the system to quickly adapt to changes in its cellular environment.
Finally, my results revealed that the system’s robustness is, on the one hand, highly
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dependent on β-catenin’s shuttling ratio if AAG was unable to translocate into the
nucleus. If, on the other hand, the destruction complex is present and active in
the nucleus, the [β-catenin/TCF] concentration is very robust towards changes in
β-catenin shuttling. From the results of the sensitivity analysis, I therefore conclude
that nucleo-cytoplasmic antagonist shuttling yields a [β-catenin/TCF] output that
is more robust against perturbations in the cellular environment in general. More-
over, it renders Wnt/β-catenin signalling particularly robust against changes in the
compartmental distribution of β-catenin.
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7. Synthesis of results and final
remarks
Over the last 30 years, Wnt/β-catenin has consolidated its role as a critical signalling
pathway in development and disease. The key player of the pathway is β-catenin.
Its activity is mainly regulated by the destruction complex consisting of APC, Axin
and GSK3. In the nucleus, complex formation of β-catenin and TCF initiates tar-
get gene expression. In 2000, it was for the first time shown that APC, a β-catenin
antagonist whose activity was believed to be restricted to the cytoplasm, is also
capable of nucleo-cytoplasmic shuttling. Since then, many cytoplasmic components
of the Wnt/β-catenin pathway have been experimentally proven to also reside in
the nucleus. However, the functional relevance of these proteins in regulating the
Wnt/β-catenin pathway in the nucleus, remains yet to be determined.
In this thesis, I investigated the role of nucleo-cytoplasmic shuttling of β-catenin
and its antagonists APC, Axin, and GSK3 in Wnt/β-catenin signalling and the re-
sulting regulation of subcellular β-catenin levels. My analysis concentrated on the
following key questions: Does the nucleo-cytoplasmic shuttling of the β-catenin an-
tagonists APC, Axin and GSK3 affect the [β-catenin/TCF] concentration, which is
considered as the output of Wnt signalling? Can the [β-catenin/TCF] concentration
be maximised by antagonist shuttling, leading to an optimised signal transduction
through the cell? How is the output of the pathway influenced by cytoplasmic and
nuclear retention of β-catenin, and by phosphorylation and subsequent degradation
of β-catenin?
To answer these questions, I established, analysed and subsequently published the
first compartmental models of the Wnt pathway: the Retention Model [Schmitz
et al., 2011] and the Degradation Model [Schmitz et al., 2013]. They are currently
the only deterministic ODE models of the Wnt/β-catenin pathway on a subcellu-
lar, compartmental scale and aim at examining the influence of nucleo-cytoplasmic
shuttling of β-catenin antagonists on the output of the pathway. These models allow
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Dynamics of the ... in the ... in the
state variable Retention Model Degradation Model
X˙1 −ν1 − ν3 −ν1 − ν3 +ν10
X˙2 −ν2 − ν3 −ν2 − ν3 +ν6 − ν11
X˙3 +ν1 − ν4 − ν5 +ν1 − ν4 − ν5
X˙4 +ν2 − ν4 +ν2 − ν4 +ν7
X˙5 +ν3 +ν3 −ν6
X˙6 +ν4 +ν4 −ν7
X˙7 −ν5 −ν5
X˙8 +ν5 +ν5
X˙9 +ν6 − ν8
X˙10 +ν7 − ν9
X˙11 +ν11
Table 7.1.: Comparison of the Retention and Degradation Model. The first column
describes the time-dependent changes of the concentrations of all proteins and pro-
tein complexes included in the models. The second column presents the reaction rates
that determine the dynamics of the variables of the Retention Model, the third column
presents the reaction rates that determine the dynamics of the variables of the Degra-
dation Model. The definitions of the state variables are given in Tables 5.1 and 6.1.
The reaction rates are defined by Equations 6.2. The reaction rates ν1−5 are used in
both models, whereas the bold characters denote the reaction rates only used in the
Degradation Model, and therefore highlight how the Degradation Model is an extension
of the Retention Model.
for the retention of β-catenin by APC, and β-catenin phosphorylation and succes-
sive degradation in the nucleus and cytoplasm, respectively.
The Retention Model and the Degradation Model share some commonalities, but
also exhibit some differences in terms of i) their structure, ii) their parametrisation
and iii) the focus of their analysis. Table 7.1 presents a survey of fundamental dif-
ferences between the two models and thus shows how the Degradation Model is an
extension of the Retention Model.
i) In terms of the model structure, common features of both models include
nucleo-cytoplasmic shuttling of β-catenin and complex formation of β-catenin and
TCF, which is regarded as the output of both models. Both models neglect mem-
brane associated events. They also have in common that an antagonist is shutt-
ling between the cytoplasm and the nucleus and interfering with β-catenin in both
cellular compartments. Shuttling assumptions are based on experimental findings
obtained by Krieghoff et al. [2006] and presume that β-catenin and its antagonists
shuttle independently of each other and that the complexes cannot cross the nuclear
envelope.
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However, the way the antagonists interfere with β-catenin is completely different in
the two models. The main structural difference is already implied by their names,
i.e. “Retention Model” and “Degradation Model”. In the Retention Model, I consid-
ered only one β-catenin antagonist – namely APC, which regulates β-catenin levels
through compartmental retention. In the Degradation Model, the destruction com-
plex, consisting of the three β-catenin antagonists APC, Axin and GSK3, can bind
and phosphorylate β-catenin, and thereby mark it for proteasomal degradation in
the cytoplasm and in the nucleus. The second major difference is that the Retention
Model is a closed system without any external input or signal, because the presence
of an external (transient) Wnt signal does not influence the total levels of APC.
The steady state solutions were therefore determined analytically. By contrast, in
the Degradation Model the impact of different Wnt signals on the output of the
system was investigated. In addition, the total amount of available β-catenin is not
conserved, as β-catenin is continuously produced and degraded. The dynamics of
the Degradation Model (steady state and transients) were obtained using computer
simulations.
ii) The default parametrisation of both models is based on the measurements
and estimations conducted by Lee et al. [2003], who developed and analysed the
“standard model” of the Wnt pathway. Many parameter values describing total
protein concentrations, dissociation constants and reaction rate constants are thus
the same. For the shuttling rate constants, both models consider ratios rather than
absolute values. The most obvious difference between the Retention Model and the
Degradation Model in terms of their parametrisation, is the huge difference in avail-
able antagonist concentration. In the Retention Model, APC is available in excess
(100 nM) compared to β-catenin (35nM). In the Degradation Model, however, the
concentration of the destruction complex is limited by the amount of available Axin,
and is thus very small (0.02 nM) [Lee et al., 2003]. Therefore, in comparison, the
concentrations of the antagonists differ by a factor of 5000.
iii) In terms of the analysis of both models, the influence of the nucleo-cytoplasmic
shuttling of β-catenin and its antagonists on the steady states of the [β-catenin/TCF]
concentration was elucidated. Surprisingly though, despite different model struc-
tures, different types of interactions and different parametrisations, the results of
the steady state analysis of the Retention Model presented in Figure 5.3 look quali-
tatively similar to the results obtained for the Degradation Model, which are shown
in Figure 6.2. This is a counter-intuitive result, which can be explained as follows:
In the Retention Model, APC retains β-catenin through complex formation in the
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compartment, in which they are localised. In the Degradation Model, the active
destruction complex binds free β-catenin, phosphorylates it and then releases it in
its inactive state, marked for subsequent degradation by the proteasome (see Fi-
gure 2.2). The destruction complex is therefore able to rapidly bind one β-catenin
molecule after another. This rapid process of binding-phosphorylation-dissociation-
degradation increases the effectively available amount of destruction complex. In
other words, the rapid binding of active β-catenin to the destruction complex and
the subsequent release of inactive β-catenin mimics a kind of retention of inactive
β-catenin, which afterwards cannot be activated anymore. The steady state anal-
yses of the models yield thus similar results for the steady state concentration of
[β-catenin/TCF], although the underlying mechanisms leading to these results are
of fundamental difference.
The two models were also investigated in terms of different aspects, as different re-
action rates and reaction rate constants were applied to the models (see Table 7.1).
For the Retention Model, the focus of the analysis was on the shuttling mechanisms
of APC and β-catenin. To this end, I investigated different functions for ν2, which
describes the shuttling of APC, and different parameter values for the shuttling rate
constant ratios for β-catenin and APC. Besides, I considered different parametrisa-
tions of ν3 and ν4, which represent the retention of β-catenin by APC, and hence
depict different compartmental retention scenarios.
In the Degradation Model the focus lay on the analysis of the following reaction
rates: In order to investigate the impact of destruction complex inhibition, the re-
action rates ν3, ν4, ν6 and ν7 were knocked out independently, as they describe the
processes of binding and inactivation of β-catenin by the destruction complex. To
account for different Wnt on/off scenarios, I considered different functions for ν11,
which describes the inactivation of the destruction complex through Wnt. Finally,
the investigation of the Degradation Model concludes with a detailed local sensitiv-
ity analysis. The Retention Model was also studied in terms of the sensitivity of
its solution towards perturbations. The results are however not presented in this
thesis, because they did not provide any new insights.
Summarising the results, the analysis of both models led to the following answers
to the initially asked questions:
1. For certain parametrisations, nucleo-cytoplasmic shuttling of β-catenin and its
antagonists can yield a spatial separation between the said proteins, which results
in a breakdown of β-catenin retention and degradation, respectively. This is fol-
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lowed by an accumulation of β-catenin leading to an increase of the [β-catenin/TCF]
concentration. Strikingly, both compartmental models I presented in this thesis re-
veal counter-intuitive behaviour of [β-catenin/TCF] signalling in response to nucleo-
cytoplasmic shuttling of β-catenin antagonists. The inhibitory effect of these pro-
teins can be alleviated due to nucleo-cytoplasmic shuttling. In fact, I showed that
nucleo-cytoplasmic shuttling of APC, Axin and GSK3 can even maximise the output
of Wnt signalling, although they are in general β-catenin antagonising proteins.
2. The investigation of the shuttling mechanisms in the Retention Model showed
that saturated protein translocation can under certain conditions be modelled by
pure diffusion. A difference in the shuttling rate constants of sufficient orders of
magnitude leads to an accumulation in either compartment, which corresponds to
saturation in translocation. Based on this result, further modelling approaches on
protein shuttling can be simplified significantly, because diffusive translocation is
described by a linear rate equation. Such a system is easier to solve than a system
containing nonlinear interactions. This result was utilised to describe the shuttling
of β-catenin and its antagonists in the Degradation Model. It is however also appli-
cable to other systems dealing with saturated bidirectional translocation processes.
3. The analysis of the Degradation Model also provided other interesting in-
sights. Elucidating the impact of destruction complex inhibition, I demonstrated
that the inhibiting the activity of the kinase GSK3 more effectively enhances the
[β-catenin/TCF] concentration than the binding of β-catenin to the destruction com-
plex. This is yet another unexpected result, as the destruction complex first binds
β-catenin, before GSK3 can phosphorylate and thus inactivate it. Furthermore, I
showed that well-balanced antagonist shuttling yields maximal relative response of
[β-catenin/TCF] to a transient Wnt signal.
4. The results of the sensitivity analysis indicated that a nuclear accumulation
of the destruction complex renders the pathway robust against fluctuations in Wnt
signalling and against changes in the compartmental distribution of β-catenin. Addi-
tionally, I showed that the total robustness of the [β-catenin/TCF] output is closely
linked to its absolute concentration. Finally, this study revealed that the compart-
mental separation of β-catenin and the destruction complex not only leads to a
maximisation, but additionally to an increased robustness of the [β-catenin/TCF]
concentration against intracellular perturbations.
These major findings demonstrate that nucleo-cytoplasmic shuttling of β-catenin
antagonists accounts for several interesting phenomena, which were discussed in de-
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7. Synthesis of results and final remarks
tail in the course of this thesis. I was able to find answers to the questions that
biologically motivated this work. This study, however, not only aims at finding
answers, but also at inspiring new wet-lab experiments. The next step would be to
experimentally verify the theoretically obtained results.
Regarding the results obtains with the Degradation Model, it is necessary to first
prove that the destruction complex is active in the nucleus. To this end, I suggest
as a possible approach to isolate the nuclei of the cells of interest and subsequently
measure if phosphorylated β-catenin has been produced in the isolated nuclei. The
detection procedure is not easy, as phosphorylated β-catenin is marked for protea-
somal degradation and therefore has a very short half-life time. Thus, one needs
experimental (microscopic) devices with high resolution to prove the existence of
phosphorylated β-catenin. Alternatively, the activity of the proteasome could be
inhibited to increase the half-life of β-catenin. In this case, the chance to detect
phosphorylated β-catenin increases.
To conclude, a great deal of the nature of β-catenin and its antagonists, as the key
players of the Wnt pathway, is known. A complete understanding of their func-
tion has to date remained elusive. More biochemical, microscopic and theoretical
studies, and a closer collaboration between experimentalists and modellers will be
important to resolve open questions about these proteins in general and their nuclear
functioning in particular.
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A. Graphical illustrations of the
sensitivity analysis
The following Figures A.1 - A.9 show the temporal evolution of the control coeffi-
cients for the [β-catenin/TCF] concentration of the Degradation Model. The control
coefficients are calculated at discrete time-points during the course of a transient
Wnt signal. The figures correspond to different points in parameter space regarding
different values for the shuttling rate constant ratios of β-catenin (K1) and AAG
(K2). Each parameter is independently perturbed by ± 1% (red: + 1%, blue: - 1
%.). The control coefficient (C(x8(t), kj)) is given on the corresponding y-axis. The
simulation time is given on the x-axis of subfigures 1-19. The panel on the bottom
right shows the sum of the absolute values of control coefficients for positive pertur-
bation for each parameter over time. Note that the index j refers to the number of
the subfigure in which the control coefficient for the respective perturbed parameter
kj is depicted. To that effect, the parameter λ for example equals k18.
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Figure A.1.: Time dependent control coefficients for K1 = 0.1 and no AAG shuttling
(i.e. AAG is only located in the cytoplasm; more β-catenin is located in the nucleus
than in the cytoplasm). Note that k2 and k−2 are not perturbed in negative direction in
order to avoid negative parameter values as the initial values of the shuttling parameters
equal zero (no AAG shuttling).
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Figure A.2.: Time dependent control coefficients for K1 = 0.1 and K2 = 1 (i.e. in this
parameterisation, β-catenin is highly concentrated in the nucleus, and AAG is equally
distributed in cytoplasm and nucleus).
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Figure A.3.: Time dependent control coefficients for K1 = 0.1 and K2 = 0.01 (i.e. both,
AAG and β-catenin, are highly concentrated in the nucleus).
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Figure A.4.: Time dependent control coefficients for K1 = 1 and no AAG shuttling
(i.e. the destruction complex AAG is only in cytoplasm; β-catenin equally distributes in
nucleus and cytoplasm). Note that k2 and k−2 are not perturbed in negative direction in
order to avoid negative parameter values as the initial values of the shuttling parameters
equal zero (no AAG shuttling).
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Figure A.5.: Time dependent control coefficients for K1 = 1 and K2 = 1 (i.e. both,
β-catenin and AAG, equally distribute in cytoplasm and nucleus).
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Figure A.6.: Time dependent control coefficients for K1 = 1 and K2 = 0.01 (i.e.
β-catenin equally distributes in cytoplasm and nucleus, whereas AAG is highly concen-
trated in the nucleus).
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Figure A.7.: Time dependent control coefficients forK1 = 10 and no AAG shuttling (i.e.
AAG is only present in the cytoplasm; but more β-catenin is located in the cytoplasm
than in the nucleus). Note that k2 and k−2 are not perturbed in negative direction in
order to avoid negative parameter values as the initial values of the shuttling parameters
equal zero (no AAG shuttling).
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Figure A.8.: Time dependent control coefficients for K1 = 10 and K2 = 1 (i.e. in
this parameterisation, β-catenin is highly concentrated in the cytoplasm, whereas AAG
equally distributes in cytoplasm and nucleus).
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Figure A.9.: Time dependent control coefficients for K1 = 10 and K2 = 0.01 (i.e. more
β-catenin is located in the cytoplasm than in the nucleus; AAG is, however, highly
concentrated in the nucleus).
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Theses
1. The Wnt/β-catenin pathway plays a key role in development and disease. The
concentration of its central signalling protein β-catenin is regulated through
the activitiy of the destruction complex, which consists of the APC, Axin and
GSK3.
2. Depending on the state of signalling, β-catenin and its antagonists APC, Axin
and GSK3 are spatio-temporally distributed in the subcellular compartments
nucleus and cytoplasm. A Wnt signal leads to nuclear accumulation of β-
catenin. Interaction of β-catenin with TCF initiates target gene expression.
3. The compartmental ODE formalism provides a modelling approach allowing to
investigate the impact of nucleo-cytoplasmic shuttling of β-catenin antagonists
on the [β-catenin/TCF] concentration, which is considered as the output of
the Wnt pathway.
4. Nucleo-cytoplasmic shuttling of β-catenin antagonists can lead to a breakdown
of retention of cytoplasmic β-catenin and can hence maximise [β-catenin/TCF]
signalling.
5. Saturated protein translocation can be modelled by pure diffusion, if the shutt-
ling rate constants are chosen appropriately.
6. Inhibition of the kinase GSK3 is more efficiently enhancing the [β-catenin/TCF]
concentration than inhibition of β-catenin’s binding to the destruction com-
plex.
7. Balanced nucleo-cytoplasmic shuttling of β-catenin antagonists yields maximal
relative response to a transient Wnt signal.
8. Nuclear accumulation of the destruction complex renders the pathway robust
against fluctuations in the extracellular Wnt signal and against changes in the
compartmental distribution of β-catenin.
9. Sensitivity analysis allows to quantify the total robustness of the [β-catenin/TCF]
concentration and demonstrates that the total robustness of [β-catenin/TCF]
is linked to its absolute concentration.
10. The described results of the model analyses provide the basis for continuative
experimental investigations of antagonist shuttling in the Wnt pathway.
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